<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Viruses</journal-id>
<journal-id journal-id-type="iso-abbrev">Viruses</journal-id>
<journal-id journal-id-type="publisher-id">viruses</journal-id>
<journal-title-group>
<journal-title>Viruses</journal-title>
</journal-title-group>
<issn pub-type="epub">1999-4915</issn>
<publisher>
<publisher-name>MDPI</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31635156</article-id>
<article-id pub-id-type="pmc">6833100</article-id>
<article-id pub-id-type="doi">10.3390/v11100966</article-id>
<article-id pub-id-type="publisher-id">viruses-11-00966</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Persistent Infection with Herpes Simplex Virus 1 and Alzheimer’s Disease—A Call to Study How Variability in Both Virus and Host may Impact Disease</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-7205-4540</contrib-id>
<name>
<surname>Mangold</surname>
<given-names>Colleen A.</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-9859-1678</contrib-id>
<name>
<surname>Szpara</surname>
<given-names>Moriah L.</given-names>
</name>
<xref ref-type="corresp" rid="c1-viruses-11-00966">*</xref>
</contrib>
</contrib-group>
<aff id="af1-viruses-11-00966">Department of Biochemistry and Molecular Biology, Center for Infectious Disease Dynamics, and the Huck Institutes of the Life Sciences, Pennsylvania State University, University Park, PA 16802, USA; <email>cav154@psu.edu</email></aff>
<author-notes>
<corresp id="c1-viruses-11-00966"><label>*</label>Correspondence: <email>moriah@psu.edu</email>; Tel.: +1-814-867-0008</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>20</day>
<month>10</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection">
<month>10</month>
<year>2019</year>
</pub-date>
<volume>11</volume>
<issue>10</issue>
<elocation-id>966</elocation-id>
<history>
<date date-type="received">
<day>23</day>
<month>7</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>14</day>
<month>10</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>© 2019 by the authors.</copyright-statement>
<copyright-year>2019</copyright-year>
<license license-type="open-access">
<license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p>
</license>
</permissions>
<abstract>
<p>Increasing attention has focused on the contributions of persistent microbial infections with the manifestation of disease later in life, including neurodegenerative conditions such as Alzheimer’s disease (AD). Current data has shown the presence of herpes simplex virus 1 (HSV-1) in regions of the brain that are impacted by AD in elderly individuals. Additionally, neuronal infection with HSV-1 triggers the accumulation of amyloid beta deposits and hyperphosphorylated tau, and results in oxidative stress and synaptic dysfunction. All of these factors are implicated in the development of AD. These data highlight the fact that persistent viral infection is likely a contributing factor, rather than a sole cause of disease. Details of the correlations between HSV-1 infection and AD development are still just beginning to emerge. Future research should investigate the relative impacts of virus strain- and host-specific factors on the induction of neurodegenerative processes over time, using models such as infected neurons in vitro, and animal models in vivo, to begin to understand their relationship with cognitive dysfunction.</p>
</abstract>
<kwd-group>
<kwd>herpes simplex virus 1</kwd>
<kwd>neuron</kwd>
<kwd>Alzheimer’s disease</kwd>
<kwd>virus strain</kwd>
<kwd>neuroinflammation</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="sec1-viruses-11-00966" sec-type="intro">
<title>1. Introduction</title>
<p>With the advent of recent advances in healthcare, the elderly population has been growing, and is expected to more than double by the year 2050 [<xref ref-type="bibr" rid="B1-viruses-11-00966">1</xref>]. Despite this positive trend in life expectancy, advanced age brings an increased risk for development of neurodegenerative diseases, many of which are devastating in their pathologies. Common features of normative brain aging include alterations in brain and neuron volume, dendritic complexity, neurotransmission, and the accumulation of specific neurotoxic proteins [<xref ref-type="bibr" rid="B2-viruses-11-00966">2</xref>,<xref ref-type="bibr" rid="B3-viruses-11-00966">3</xref>]. It is believed that the manifestation of these alterations contributes in part to the neurodegenerative processes and cognitive deficits associated with advanced age. Despite these implications, the etiology of many of the hallmark changes in the brain that occur with aging remain unclear. However, it is widely believed that the induction of low levels of inflammation, combined with decreases in the clearance of misfolded proteins, may play critical roles in neurodegeneration and cognitive decline [<xref ref-type="bibr" rid="B4-viruses-11-00966">4</xref>,<xref ref-type="bibr" rid="B5-viruses-11-00966">5</xref>,<xref ref-type="bibr" rid="B6-viruses-11-00966">6</xref>].</p>
<p>Alzheimer’s disease (AD) and related dementias affect over 40 million people globally, and this number is expected to rise with the steady increase in the aged population [<xref ref-type="bibr" rid="B7-viruses-11-00966">7</xref>]. AD is characterized by behavioral and psychological symptoms including, but not limited to, memory loss, agitation, anxiety, depression, and delusions [<xref ref-type="bibr" rid="B8-viruses-11-00966">8</xref>]. There are two main types of AD, familial and sporadic. While the symptoms of disease between the two types are indistinguishable from each other, the age of onset, as well as family history, differ. Familial AD is thought to be triggered by heritable elements, and typically begins to manifest in patients before the age of 60. In contrast, the exact causes of sporadic AD are relatively complex and ill-defined, involving a number of environmental and genetic factors, with symptoms often beginning to appear after age 60 to 65 [<xref ref-type="bibr" rid="B9-viruses-11-00966">9</xref>,<xref ref-type="bibr" rid="B10-viruses-11-00966">10</xref>,<xref ref-type="bibr" rid="B11-viruses-11-00966">11</xref>,<xref ref-type="bibr" rid="B12-viruses-11-00966">12</xref>,<xref ref-type="bibr" rid="B13-viruses-11-00966">13</xref>,<xref ref-type="bibr" rid="B14-viruses-11-00966">14</xref>,<xref ref-type="bibr" rid="B15-viruses-11-00966">15</xref>,<xref ref-type="bibr" rid="B16-viruses-11-00966">16</xref>]. Increased inflammation in the brain with advanced age, combined with the accumulation of neurotoxic proteins, including amyloid beta and hyperphosphorylated tau, are believed to be key factors in the manifestation of sporadic AD [<xref ref-type="bibr" rid="B17-viruses-11-00966">17</xref>,<xref ref-type="bibr" rid="B18-viruses-11-00966">18</xref>].</p>
<p>There is a growing body of literature linking infection by specific viruses, bacteria, and fungi with the development of neurodegenerative diseases later in life, including AD, Parkinson’s disease (PD), amylotropic lateral sclerosis (ALS), and multiple sclerosis (MS) [<xref ref-type="bibr" rid="B19-viruses-11-00966">19</xref>,<xref ref-type="bibr" rid="B20-viruses-11-00966">20</xref>]. It has been hypothesized that an increased proinflammatory state associated with advanced age may in part be due to the immune system’s continuous battle with microbial antigens over time [<xref ref-type="bibr" rid="B4-viruses-11-00966">4</xref>]. This chronic parainflammation would in turn contribute to the development of neurodegenerative disease [<xref ref-type="bibr" rid="B6-viruses-11-00966">6</xref>]. Additionally, recent evidence suggests that amyloid beta, a clinical indicator of AD, may serve as an antimicrobial peptide that restricts pathogen movement and disrupts microbial membranes [<xref ref-type="bibr" rid="B21-viruses-11-00966">21</xref>,<xref ref-type="bibr" rid="B22-viruses-11-00966">22</xref>]. Continuous production of amyloid beta in response to persistent microbial infection over time may lead to the pathological accumulations associated with AD. Together, these data support the hypothesis that infection by different microbes may contribute to AD pathogenesis [<xref ref-type="bibr" rid="B23-viruses-11-00966">23</xref>]. This may be especially true for persistent infections localized within neurons, such as alphaherpesviruses. Infection with herpes simplex virus 1 (HSV-1) in particular has been linked to the development of neurodegenerative disease including sporadic AD, and has also been implicated in the manifestation of cognitive deficits observed in patients with schizophrenia [<xref ref-type="bibr" rid="B19-viruses-11-00966">19</xref>,<xref ref-type="bibr" rid="B24-viruses-11-00966">24</xref>,<xref ref-type="bibr" rid="B25-viruses-11-00966">25</xref>,<xref ref-type="bibr" rid="B26-viruses-11-00966">26</xref>,<xref ref-type="bibr" rid="B27-viruses-11-00966">27</xref>].</p>
<p>HSV-1 is a double-stranded DNA virus that infects over half the global population, and triggers the manifestation of recurrent painful orofacial and/or genital lesions [<xref ref-type="bibr" rid="B28-viruses-11-00966">28</xref>]. HSV-1 infection can cause infectious keratitis, and in rare cases encephalitis [<xref ref-type="bibr" rid="B29-viruses-11-00966">29</xref>], and can lead to dangerous neonatal infection in roughly 4000 infants annually [<xref ref-type="bibr" rid="B30-viruses-11-00966">30</xref>]. HSV-1 actively replicates in mucosal epithelial cells, and subsequently enters innervating peripheral sensory nerve endings [<xref ref-type="bibr" rid="B31-viruses-11-00966">31</xref>]. The virus then traffics in a retrograde direction back to neuronal cell bodies located in the peripheral ganglia. Once in the neuronal cell body, it enters a nonreplicative, latent stage, where viral DNA becomes circularized to form an episome and lytic gene expression is silenced [<xref ref-type="bibr" rid="B32-viruses-11-00966">32</xref>,<xref ref-type="bibr" rid="B33-viruses-11-00966">33</xref>]. The ability of HSV-1 to infect and maintain a nonreplicative state in peripheral neurons allows for lifelong infection, as the only approved therapeutics used to treat HSV-1 target actively proliferating virus. Numerous recent publications have linked HSV-1 infection and/or seropositivity with the development of sporadic AD later in life [<xref ref-type="bibr" rid="B24-viruses-11-00966">24</xref>,<xref ref-type="bibr" rid="B26-viruses-11-00966">26</xref>,<xref ref-type="bibr" rid="B34-viruses-11-00966">34</xref>,<xref ref-type="bibr" rid="B35-viruses-11-00966">35</xref>,<xref ref-type="bibr" rid="B36-viruses-11-00966">36</xref>,<xref ref-type="bibr" rid="B37-viruses-11-00966">37</xref>,<xref ref-type="bibr" rid="B38-viruses-11-00966">38</xref>,<xref ref-type="bibr" rid="B39-viruses-11-00966">39</xref>,<xref ref-type="bibr" rid="B40-viruses-11-00966">40</xref>,<xref ref-type="bibr" rid="B41-viruses-11-00966">41</xref>]. It is possible that latent HSV-1 infection may over time cause the accumulation of misfolded proteins and enhance local persistent parainflammation, leading to the manifestation of disease. However, at present, gaps in knowledge exist definitively linking HSV-1 infection with the development of AD pathology. It is important to note that HSV-1 strains isolated from independent patients can differ in 2–4% of the viral genome [<xref ref-type="bibr" rid="B42-viruses-11-00966">42</xref>,<xref ref-type="bibr" rid="B43-viruses-11-00966">43</xref>,<xref ref-type="bibr" rid="B44-viruses-11-00966">44</xref>,<xref ref-type="bibr" rid="B45-viruses-11-00966">45</xref>,<xref ref-type="bibr" rid="B46-viruses-11-00966">46</xref>,<xref ref-type="bibr" rid="B47-viruses-11-00966">47</xref>,<xref ref-type="bibr" rid="B48-viruses-11-00966">48</xref>]. Individual strains of HSV-1 exhibit differing abilities to reach the central nervous system (CNS) when inoculated at peripheral sites in animal models, highlighting strain-specific differences in neuroinvasion [<xref ref-type="bibr" rid="B49-viruses-11-00966">49</xref>,<xref ref-type="bibr" rid="B50-viruses-11-00966">50</xref>]. Despite the known diversity that exists between individual circulating HSV-1 strains, the collective impacts of these viral genomic differences and host genetic predisposition(s) on disease development and severity remain unclear. Relatively few studies have sought to detail the virus strain- and/or host-specific characteristics that may potentially influence the dynamic range of HSV impacts on disease outcomes later in life [<xref ref-type="bibr" rid="B51-viruses-11-00966">51</xref>,<xref ref-type="bibr" rid="B52-viruses-11-00966">52</xref>,<xref ref-type="bibr" rid="B53-viruses-11-00966">53</xref>,<xref ref-type="bibr" rid="B54-viruses-11-00966">54</xref>,<xref ref-type="bibr" rid="B55-viruses-11-00966">55</xref>,<xref ref-type="bibr" rid="B56-viruses-11-00966">56</xref>,<xref ref-type="bibr" rid="B57-viruses-11-00966">57</xref>,<xref ref-type="bibr" rid="B58-viruses-11-00966">58</xref>,<xref ref-type="bibr" rid="B59-viruses-11-00966">59</xref>].</p>
<p>In this review, we aim to emphasize the importance of filling these knowledge gaps, as this may help better inform physicians as to the choice and aggressiveness of AD therapy on a more individualized basis (e.g., the use of anti-herpetic medication [<xref ref-type="bibr" rid="B41-viruses-11-00966">41</xref>]). We begin here by discussing the specific terminology used to describe viral infection phenotypes, since many of the labs working in the emerging field of microbial links to AD are not classically trained in virology. We discuss how the terms chronic, latent, and persistent are used in the literature to describe specific characteristics of HSV-1 infection. We follow this by detailing the contributions of neuroinflammation and neurotoxic protein accumulation to the development of neurodegenerative processes and disease. We then discuss the potential connections between persistent HSV-1 infection, neuroinflammation, and neurotoxic protein accumulation, as well as the hypothesized mechanisms underlying HSV-1-induced disease development. We close by emphasizing the importance of characterizing virus strain- and host-specific interactions on an individual basis, since these may influence the potential for disease development later in life in HSV-1-infected patients. When investigating these interactions, it will be important to consider how factors such as host or animal model, age of first exposure, virus strain, inoculum dosage, frequency of exposure, comorbid conditions, and other factors may influence disease outcome in both natural and experimental settings (<xref ref-type="fig" rid="viruses-11-00966-f001">Figure 1</xref>).</p>
</sec>
<sec id="sec2-viruses-11-00966">
<title>2. Definitions of Latent, Persistent, and Chronic Viral Infection</title>
<p>In order to understand the contribution of infection with a pathogen to the development of disease later in life, a clear understanding and precise description of viral infection characteristics is required. In many instances in the literature, the terms “latent”, “persistent”, and “chronic” are used interchangeably to describe the infection dynamics of different viruses. This becomes problematic when trying to frame the discussion of disease development later in life, with host-virus interactions that occur over the course of a patient’s lifetime.</p>
<sec id="sec2dot1-viruses-11-00966">
<title>2.1. Definitions</title>
<p>Both latent and chronic infection can be defined as specific subtypes of a persistent viral infection where the virus is never cleared (<xref ref-type="fig" rid="viruses-11-00966-f002">Figure 2</xref>). These are unlike acute viral infections, such as influenza [<xref ref-type="bibr" rid="B60-viruses-11-00966">60</xref>]. Instead, during persistent infections, viral genomes reside permanently within specific host cells by integrating into cellular DNA or by forming episomes [<xref ref-type="bibr" rid="B60-viruses-11-00966">60</xref>]. In the case of HSV-1, long term persistence occurs via episomes held in the nuclei of latently infected neurons. Although quite similar in definition, latent and chronic infections have specific characteristics that set them distinctly apart. Infection with a virus that is able to establish a latent state in its host results in recurrent disease over a patient’s lifetime. In between instances of active disease, there is a lack of infectious virus production. In contrast, a chronic viral infection continuously produces infectious virus, regardless of overt disease status [<xref ref-type="bibr" rid="B60-viruses-11-00966">60</xref>].</p>
</sec>
<sec id="sec2dot2-viruses-11-00966">
<title>2.2. HSV-1 Causes a Persistent, Latent Infection in Neurons</title>
<p>The lifecycle of HSV-1 requires lytic infection of epithelial cells and quiescent infection of neurons [<xref ref-type="bibr" rid="B31-viruses-11-00966">31</xref>]. Localization within neurons has been theorized to provide HSV-1 with an “immunologically-privileged” reservoir in which to effectively evade immune clearance [<xref ref-type="bibr" rid="B60-viruses-11-00966">60</xref>]. However, neurons cannot be considered immune-privileged, given the diversity of immune signaling that is known to occur in the nervous system [<xref ref-type="bibr" rid="B61-viruses-11-00966">61</xref>,<xref ref-type="bibr" rid="B62-viruses-11-00966">62</xref>,<xref ref-type="bibr" rid="B63-viruses-11-00966">63</xref>,<xref ref-type="bibr" rid="B64-viruses-11-00966">64</xref>,<xref ref-type="bibr" rid="B65-viruses-11-00966">65</xref>,<xref ref-type="bibr" rid="B66-viruses-11-00966">66</xref>,<xref ref-type="bibr" rid="B67-viruses-11-00966">67</xref>,<xref ref-type="bibr" rid="B68-viruses-11-00966">68</xref>] (see <xref ref-type="sec" rid="sec3dot1-viruses-11-00966">Section 3.1</xref> for further discussion). Given that infection endures over the course of a patient’s lifetime and is never cleared, HSV-1 infection is defined as persistent. The current paradigm holds that while HSV-1 is able to actively replicate in mucosal epithelial cells, lytic gene expression is repressed in neurons [<xref ref-type="bibr" rid="B31-viruses-11-00966">31</xref>]. This occurs as a consequence of a number of molecular events, including epigenetic modification, changes in host cell signaling, and heterochromatin formation [<xref ref-type="bibr" rid="B31-viruses-11-00966">31</xref>,<xref ref-type="bibr" rid="B33-viruses-11-00966">33</xref>,<xref ref-type="bibr" rid="B69-viruses-11-00966">69</xref>,<xref ref-type="bibr" rid="B70-viruses-11-00966">70</xref>]. However, low levels of lytic viral gene transcription may still occur in latently-infected neurons. Historically, the only viral transcripts thought to be expressed were the latency-associated transcripts (LATs), which are expressed in roughly 30% of HSV-1-infected neurons in vivo [<xref ref-type="bibr" rid="B33-viruses-11-00966">33</xref>,<xref ref-type="bibr" rid="B71-viruses-11-00966">71</xref>,<xref ref-type="bibr" rid="B72-viruses-11-00966">72</xref>,<xref ref-type="bibr" rid="B73-viruses-11-00966">73</xref>]. These transcripts are stable products of RNA splicing that are derived from transcription of the repeat regions neighboring the central unique region of the HSV-1 genome [<xref ref-type="bibr" rid="B74-viruses-11-00966">74</xref>,<xref ref-type="bibr" rid="B75-viruses-11-00966">75</xref>,<xref ref-type="bibr" rid="B76-viruses-11-00966">76</xref>]. Functions encoded by the LAT locus lead to repression of lytic viral gene expression, thereby allowing for the establishment of latency in neurons [<xref ref-type="bibr" rid="B33-viruses-11-00966">33</xref>,<xref ref-type="bibr" rid="B77-viruses-11-00966">77</xref>,<xref ref-type="bibr" rid="B78-viruses-11-00966">78</xref>,<xref ref-type="bibr" rid="B79-viruses-11-00966">79</xref>,<xref ref-type="bibr" rid="B80-viruses-11-00966">80</xref>,<xref ref-type="bibr" rid="B81-viruses-11-00966">81</xref>]. Active repression of lytic viral gene expression provides for long-term infection as neuronal apoptosis is avoided [<xref ref-type="bibr" rid="B82-viruses-11-00966">82</xref>]. Additionally, transmission can continue over the course of the patient’s lifetime during periods of reactivation [<xref ref-type="bibr" rid="B33-viruses-11-00966">33</xref>,<xref ref-type="bibr" rid="B79-viruses-11-00966">79</xref>,<xref ref-type="bibr" rid="B83-viruses-11-00966">83</xref>]. Similar to the LATs, microRNAs (miRNAs) encoded within the LAT region also regulate lytic HSV-1 gene expression and play important roles in the establishment and maintenance of latency [<xref ref-type="bibr" rid="B84-viruses-11-00966">84</xref>,<xref ref-type="bibr" rid="B85-viruses-11-00966">85</xref>].</p>
<p>While it is true that the most abundant viral transcripts present during latency are the LATs and miRNAs, other data suggests that low levels of HSV-1 lytic gene expression may occur on a regular basis in specific populations of infected neurons. In the latently infected trigeminal ganglia (TG) of mice and rabbits, low-level expression of ICP4 and thymidine kinase is evident [<xref ref-type="bibr" rid="B86-viruses-11-00966">86</xref>,<xref ref-type="bibr" rid="B87-viruses-11-00966">87</xref>]. Within the TG of latently-infected mice, a small population of neurons (1 neuron per 10 TG) demonstrates lytic viral gene and protein expression, as well as viral DNA replication [<xref ref-type="bibr" rid="B88-viruses-11-00966">88</xref>]. This occurs in the absence of infectious virion production and is characterized by the presence of immune cell infiltration [<xref ref-type="bibr" rid="B88-viruses-11-00966">88</xref>,<xref ref-type="bibr" rid="B89-viruses-11-00966">89</xref>]. This suggests that lytic viral gene expression is rapidly detected and addressed by the immune system. These data also indicate that rather than many latently-infected neurons within the TG expressing low levels of lytic viral genes, small populations express high levels [<xref ref-type="bibr" rid="B88-viruses-11-00966">88</xref>], inducing prompt immune responses in the host’s attempt to maintain viral latency and avoid neuronal apoptosis.</p>
<p>Although lytic gene expression is observed, the presence of infectious virus in latently-infected ganglia is not [<xref ref-type="bibr" rid="B88-viruses-11-00966">88</xref>]. Recent data suggests that reactivation from latency occurs in phases [<xref ref-type="bibr" rid="B90-viruses-11-00966">90</xref>,<xref ref-type="bibr" rid="B91-viruses-11-00966">91</xref>], which may also generate low levels of lytic gene expression. This may be an interesting parallel to the multiple stages of latency observed in Epstein–Barr virus infection [<xref ref-type="bibr" rid="B92-viruses-11-00966">92</xref>,<xref ref-type="bibr" rid="B93-viruses-11-00966">93</xref>]. Taken together, it can be hypothesized that HSV-1 causes a latent infection in neurons that “simmers” beneath the surface. This triggers persistent local parainflammation and immune responses to the low-level expression of lytic viral genes, which may aid in dampening viral gene expression and help maintain latency [<xref ref-type="bibr" rid="B94-viruses-11-00966">94</xref>]. Parainflammation can be defined as a state in which inflammation is higher than basal, homeostatic levels, but less than a full inflammatory reaction [<xref ref-type="bibr" rid="B95-viruses-11-00966">95</xref>]. One caveat to this assertion is that the studies referenced here were performed using mouse and rabbit in vivo models of HSV-1 latency, and HSV-1 is a highly human-specific virus in natural settings. However, these data are supported by evidence in human tissue demonstrating retrieval of HSV-1 from the trigeminal ganglia of cadavers, as well as the identification of lymphocyte infiltration therein [<xref ref-type="bibr" rid="B96-viruses-11-00966">96</xref>].</p>
</sec>
</sec>
<sec id="sec3-viruses-11-00966">
<title>3. Neuroinflammation, β Amyloid Plaques, and Neurodegeneration—Connections with Cognitive Decline and Alzheimer’s Disease</title>
<sec id="sec3dot1-viruses-11-00966">
<title>3.1. Expression of Immune Proteins in the Brain—Contributions of Neuroinflammation to Synaptic Dysfunction</title>
<p>HSV-1 establishes a latent, persistent viral infection that resides within neurons. What impacts does this type of infection have on the nervous system? What are the impacts of inflammation and inflammatory mediators in neural tissue? The concept of the nervous system as an immune-privileged site is derived from studies detailing the lack of cytotoxic T lymphocyte-mediated cell death in virus-infected neurons [<xref ref-type="bibr" rid="B97-viruses-11-00966">97</xref>], as well as the inability of grafted tissue to be rejected when transplanted onto nervous tissue [<xref ref-type="bibr" rid="B98-viruses-11-00966">98</xref>,<xref ref-type="bibr" rid="B99-viruses-11-00966">99</xref>,<xref ref-type="bibr" rid="B100-viruses-11-00966">100</xref>]. However, recent studies have detailed the contributions of immune proteins from both the innate and adaptive immune systems to neurodevelopment, normal brain homeostatic functions, neurodegeneration, and injury [<xref ref-type="bibr" rid="B61-viruses-11-00966">61</xref>,<xref ref-type="bibr" rid="B62-viruses-11-00966">62</xref>,<xref ref-type="bibr" rid="B63-viruses-11-00966">63</xref>,<xref ref-type="bibr" rid="B64-viruses-11-00966">64</xref>,<xref ref-type="bibr" rid="B65-viruses-11-00966">65</xref>,<xref ref-type="bibr" rid="B66-viruses-11-00966">66</xref>,<xref ref-type="bibr" rid="B67-viruses-11-00966">67</xref>]. Specifically, proteins including the major histocompatibility class I (MHCI) protein, as well as the complement protein C1q and its receptor C3, are involved in synaptic refinement and neuronal connectivity [<xref ref-type="bibr" rid="B62-viruses-11-00966">62</xref>,<xref ref-type="bibr" rid="B66-viruses-11-00966">66</xref>,<xref ref-type="bibr" rid="B67-viruses-11-00966">67</xref>]. Additionally, other inflammatory mediators are known to play critical roles in processes including learning and memory, neurodevelopment, and in the regulation of synapse strength [<xref ref-type="bibr" rid="B68-viruses-11-00966">68</xref>]. These immune proteins and their receptors are expressed on neurons, glial cells, and microglia, which are the resident immune cells of the brain. Dysregulation of these neuroimmune pathways could underlie the premature synaptic loss that is associated with cognitive decline, neurodegeneration, and the development of neuropsychiatric disorders [<xref ref-type="bibr" rid="B67-viruses-11-00966">67</xref>].</p>
<p>Aberrant expression of immune mediators in the brain is implicated in a number of neurological diseases [<xref ref-type="bibr" rid="B67-viruses-11-00966">67</xref>,<xref ref-type="bibr" rid="B101-viruses-11-00966">101</xref>]. This is particularly true in elderly populations as with increased age, there is an overall induction of inflammation. This has been termed “inflamm-aging”, a phenomenon describing the overall subclinical, chronic inflammatory status observed in elderly individuals [<xref ref-type="bibr" rid="B4-viruses-11-00966">4</xref>]. For example, increased expression of neuroimmune proteins such as MHCI is observed with increased age in the brain [<xref ref-type="bibr" rid="B102-viruses-11-00966">102</xref>,<xref ref-type="bibr" rid="B103-viruses-11-00966">103</xref>,<xref ref-type="bibr" rid="B104-viruses-11-00966">104</xref>]. MHCI expression in the brain is associated with the regulation of neurite outgrowth and synaptic connectivity during development [<xref ref-type="bibr" rid="B62-viruses-11-00966">62</xref>,<xref ref-type="bibr" rid="B66-viruses-11-00966">66</xref>]. However, aberrant expression of MHCI in the aged brain may trigger synapse loss. Synapse loss and atrophy in the absence of overt neurodegeneration is observed with advanced age [<xref ref-type="bibr" rid="B105-viruses-11-00966">105</xref>,<xref ref-type="bibr" rid="B106-viruses-11-00966">106</xref>], and premature synapse loss has been hypothesized to precede the onset of neurodegenerative disease and trigger cognitive decline [<xref ref-type="bibr" rid="B67-viruses-11-00966">67</xref>]. Synaptic dysfunction is also associated with AD, often as a consequence of amyloid beta and tau pathology [<xref ref-type="bibr" rid="B26-viruses-11-00966">26</xref>,<xref ref-type="bibr" rid="B107-viruses-11-00966">107</xref>,<xref ref-type="bibr" rid="B108-viruses-11-00966">108</xref>,<xref ref-type="bibr" rid="B109-viruses-11-00966">109</xref>,<xref ref-type="bibr" rid="B110-viruses-11-00966">110</xref>,<xref ref-type="bibr" rid="B111-viruses-11-00966">111</xref>,<xref ref-type="bibr" rid="B112-viruses-11-00966">112</xref>]. Together, these data indicate that overall inductions in the expression of inflammatory mediators with increased age may contribute to the manifestation of neurodegenerative disease including AD [<xref ref-type="bibr" rid="B18-viruses-11-00966">18</xref>].</p>
</sec>
<sec id="sec3dot2-viruses-11-00966">
<title>3.2. Pathological Hallmarks of AD</title>
<p>It is clear that inflammatory processes play a role in aberrant synaptic alterations over time, and potentially with the development of neurodegenerative disease. Could persistent infection with HSV-1 influence these neuroinflammatory processes and also contribute to AD pathology? The presentation of AD is initially diagnosed by a psychological evaluation indicating the manifestation of distinct changes in behavior and memory [<xref ref-type="bibr" rid="B8-viruses-11-00966">8</xref>]. However, clinical diagnosis involves the identification of extracellular senile plaques, typically composed of amyloid beta and intracellular neurofilbrillary tau tangles, in areas of the brain critical for learning and memory [<xref ref-type="bibr" rid="B113-viruses-11-00966">113</xref>]. Amyloid beta is composed of extracellular insoluble misfolded protein that aggregates and accumulates in the brain [<xref ref-type="bibr" rid="B114-viruses-11-00966">114</xref>]. Accumulation of amyloid beta is present both in the brains of cognitively normal elderly individuals as well as in the brains of AD patients, suggesting that the presence of amyloid beta aggregates is not the sole cause of AD [<xref ref-type="bibr" rid="B113-viruses-11-00966">113</xref>,<xref ref-type="bibr" rid="B115-viruses-11-00966">115</xref>,<xref ref-type="bibr" rid="B116-viruses-11-00966">116</xref>,<xref ref-type="bibr" rid="B117-viruses-11-00966">117</xref>,<xref ref-type="bibr" rid="B118-viruses-11-00966">118</xref>]. While the presence of amyloid beta peptides and/or plaques has been positively correlated with cognitive deficits [<xref ref-type="bibr" rid="B116-viruses-11-00966">116</xref>,<xref ref-type="bibr" rid="B118-viruses-11-00966">118</xref>,<xref ref-type="bibr" rid="B119-viruses-11-00966">119</xref>], the relative contributions of amyloid beta plaques versus neurofibrillary tangles to dementia severity is a topic of debate [<xref ref-type="bibr" rid="B117-viruses-11-00966">117</xref>]. Soluble amyloid beta is generated following cleavage of amyloid precursor protein (APP), a transmembrane protein involved in the formation of synapses, and in learning and memory [<xref ref-type="bibr" rid="B120-viruses-11-00966">120</xref>,<xref ref-type="bibr" rid="B121-viruses-11-00966">121</xref>]. Under normal conditions, soluble amyloid beta is hypothesized to be neurotrophic and participates in synaptogenesis and synaptic activity, neurodevelopment, learning and memory, and may have antioxidant properties [<xref ref-type="bibr" rid="B114-viruses-11-00966">114</xref>]. Additionally, several research groups have indicated a role for amyloid beta in the restriction of pathogen movement and survival during microbial infection [<xref ref-type="bibr" rid="B21-viruses-11-00966">21</xref>,<xref ref-type="bibr" rid="B22-viruses-11-00966">22</xref>], making it an important factor in cellular immune responses, and providing a potential window for the involvement of HSV-1 in AD-associated neuropathology. However over-production of amyloid beta combined with decreased clearance of its aggregates may be neurotoxic and result in the formation of insoluble plaques [<xref ref-type="bibr" rid="B114-viruses-11-00966">114</xref>]. As such, a delicate balance of amyloid beta production and clearance needs to be maintained, and it is this aspect which may be dysregulated with advanced age.</p>
<p>Another clinical indicator of AD is the presence of intraneuronal neurofibrillary tangles, which are composed of hyperphosphorylated tau [<xref ref-type="bibr" rid="B113-viruses-11-00966">113</xref>]. Tau protein functions in microtubule assembly, where it binds to and stabilizes microtubules. When tau becomes phosphorylated, it does not bind microtubules as readily, resulting in microtubule disassembly and ultimately self-aggregation of tau [<xref ref-type="bibr" rid="B26-viruses-11-00966">26</xref>,<xref ref-type="bibr" rid="B122-viruses-11-00966">122</xref>]. Aberrant phosphorylation of tau results in distinct changes in neuronal cytoarchitecture [<xref ref-type="bibr" rid="B122-viruses-11-00966">122</xref>,<xref ref-type="bibr" rid="B123-viruses-11-00966">123</xref>,<xref ref-type="bibr" rid="B124-viruses-11-00966">124</xref>], which may negatively impact synaptic stability and cognitive function. Precise regulation of tau phosphorylation is achieved via the actions of several different kinases and phosphatases [<xref ref-type="bibr" rid="B125-viruses-11-00966">125</xref>,<xref ref-type="bibr" rid="B126-viruses-11-00966">126</xref>]. These processes may become dysregulated with advanced age, resulting in increased accumulation of hyperphosphorylated tau, which is correlated with cognitive deficits observed in AD. Similar to amyloid beta, the presence of neurofibrillary degeneration is observed in specific areas in the brains of normal, non-demented elderly individuals as well as in AD patients, but not in younger individuals [<xref ref-type="bibr" rid="B127-viruses-11-00966">127</xref>,<xref ref-type="bibr" rid="B128-viruses-11-00966">128</xref>]. This suggests that neurofibrillary degeneration increases with age, however, there is no one-to-one relationship between the formation of neurofibrillary tangles and AD. As such, controversy exists surrounding the relative contributions of amyloid beta plaques and neurofibrillary tangles on the manifestation of cognitive deficits in AD, as well as whether these pathologies are true indicators of disease [<xref ref-type="bibr" rid="B117-viruses-11-00966">117</xref>,<xref ref-type="bibr" rid="B129-viruses-11-00966">129</xref>]. These data highlight that the etiology of sporadic AD is complex, and there is likely more than one mechanism that underlies disease pathology and cognitive deficits.</p>
</sec>
</sec>
<sec id="sec4-viruses-11-00966">
<title>4. Possible Connections between Persistent HSV-1 Infection and AD</title>
<sec id="sec4dot1-viruses-11-00966">
<title>4.1. Persistent HSV-1 Infection and Neuroinflammation</title>
<p>The ability of HSV-1 to maintain a persistent infection within neurons allows the virus to evade immune clearance, resulting in lifelong infection. Although the benefits of neuronal infection for HSV-1 pathogenesis and transmission are quite clear, the long-term consequences of infection on host neurons later in life have yet to be fully elucidated. Repeated cycles of HSV-1 latency and reactivation over time may cause detrimental effects to infected neurons as well as the surrounding microenvironment, leading to subsequent disease (<xref ref-type="fig" rid="viruses-11-00966-f003">Figure 3</xref>) [<xref ref-type="bibr" rid="B24-viruses-11-00966">24</xref>]. This is true not only in the nervous system, but also in other niches throughout the body. For example, HSV-1 infection is linked to the development of coronary heart disease and myocardial infarction, and has been identified within atherosclerotic lesions [<xref ref-type="bibr" rid="B130-viruses-11-00966">130</xref>,<xref ref-type="bibr" rid="B131-viruses-11-00966">131</xref>,<xref ref-type="bibr" rid="B132-viruses-11-00966">132</xref>]. It is possible that a history of frequent HSV reactivation concurrent with increased anti-HSV antibody levels [<xref ref-type="bibr" rid="B133-viruses-11-00966">133</xref>,<xref ref-type="bibr" rid="B134-viruses-11-00966">134</xref>] may increase the risk for lethal myocardial infarction and coronary heart disease [<xref ref-type="bibr" rid="B134-viruses-11-00966">134</xref>,<xref ref-type="bibr" rid="B135-viruses-11-00966">135</xref>]. </p>
<p>Recent data has implicated persistent infection with HSV-1 to the development of AD. The main site of HSV-1 latency is in the peripheral nervous system (PNS), and it is thought to only rarely enter the CNS. So how then can peripheral HSV-1 infection trigger neurodegenerative processes in the CNS? One of two hypotheses may be possible. The first hypothesis is that chronic peripheral inflammation, combined with increases in blood-brain-barrier permeability with advanced age, may lead to higher immune cell and inflammatory mediator infiltration into the CNS, resulting in aberrant neuroinflammation and neurodegeneration. The second hypothesis is that HSV-1 may travel via synaptically connected neurons beyond the peripheral ganglia, and maintain latent subclinical infection within the CNS, causing local neuroinflammation and neurodegeneration in regions of the brain often affected by AD. Evidence discussed below exists to support both of these hypotheses, suggesting that these are not mutually exclusive ideas.</p>
<p>With advanced age, there is an increase in blood-brain-barrier permeability, as well as immunosenescence, a term used to describe the gradual dysfunction of the immune system and overall reduction of immune responses to different perturbations [<xref ref-type="bibr" rid="B137-viruses-11-00966">137</xref>,<xref ref-type="bibr" rid="B138-viruses-11-00966">138</xref>]. With the onset of immunosenescence, it is possible that immune control of HSV-1 latency in peripheral ganglia may diminish, similar to what is seen with other herpesviruses, making infection more chronic, rather than latent, at later stages in life [<xref ref-type="bibr" rid="B139-viruses-11-00966">139</xref>]. Increased cycling between latency and reactivation may induce enhanced expression of inflammatory factors, such as cytokines, that are targeted at dampening lytic HSV-1 gene expression in infected neurons. Over time, focal immune cell infiltration in the peripheral ganglia may increase. If this were to occur simultaneously with age-associated increases in blood-brain-barrier permeability [<xref ref-type="bibr" rid="B137-viruses-11-00966">137</xref>], this could potentially lead to higher than normal levels of immune cell and inflammatory mediator infiltration into the brain. Even if increased cycling between latency and reactivation did not occur with increasing age, chronic local parainflammation in the peripheral ganglia that is targeted at maintaining HSV-1 latency, combined with increased blood-brain-barrier permeability, could lead to the same outcome of enhanced immune infiltration into the brain.</p>
<p>If there are frequent, low-levels of inflammation in the nervous system as a result of immune-control of latent HSV-1 infection [<xref ref-type="bibr" rid="B88-viruses-11-00966">88</xref>,<xref ref-type="bibr" rid="B89-viruses-11-00966">89</xref>,<xref ref-type="bibr" rid="B94-viruses-11-00966">94</xref>], then local alterations in synapse function and aberrant synaptic pruning may also occur (<xref ref-type="fig" rid="viruses-11-00966-f003">Figure 3</xref>). This could result in the development of cognitive impairment later in life, and perhaps ultimately AD. However, it is likely that latent infection of HSV-1 in the peripheral ganglia is not the only factor contributing to enhanced peripheral and/or central inflammation. For example, expression of the immune mediator IL-6 is dysregulated with advanced age [<xref ref-type="bibr" rid="B140-viruses-11-00966">140</xref>]. This results in enhanced circulating serum IL-6 concentrations, which is hypothesized to play detrimental roles in the progression of many different age-associated complications [<xref ref-type="bibr" rid="B140-viruses-11-00966">140</xref>]. As such, persistent peripheral HSV-1 infection is more likely to be a contributing factor, rather than a sole trigger, of the process of inflamm-aging [<xref ref-type="bibr" rid="B4-viruses-11-00966">4</xref>].</p>
<p>There is also the possibility that HSV-1 may enter neurons of the CNS over the course of a patient’s lifetime, during one of the many cycles of latency and reactivation. This could potentially underlie the introduction of focal areas of inflammation into specific areas of the CNS known to be affected in AD. HSV-1 has been identified in the brains of immunosuppressed individuals [<xref ref-type="bibr" rid="B141-viruses-11-00966">141</xref>]. There is also evidence of HSV-1 in the brains of AD patients as well as in healthy elderly brains, suggesting that central nervous system infection with HSV-1 is not the only risk factor for AD development [<xref ref-type="bibr" rid="B142-viruses-11-00966">142</xref>,<xref ref-type="bibr" rid="B143-viruses-11-00966">143</xref>,<xref ref-type="bibr" rid="B144-viruses-11-00966">144</xref>,<xref ref-type="bibr" rid="B145-viruses-11-00966">145</xref>,<xref ref-type="bibr" rid="B146-viruses-11-00966">146</xref>,<xref ref-type="bibr" rid="B147-viruses-11-00966">147</xref>]. Importantly, samples derived from the brains of younger individuals do not have detectable levels of HSV-1 [<xref ref-type="bibr" rid="B145-viruses-11-00966">145</xref>]. Together, these data suggest that increased penetrance of HSV-1 into the brain occurs with advanced age. It has been hypothesized that HSV-1 can travel to regions of the brain that are important for learning and memory, as areas such as the frontal and temporal lobes are preferentially affected during acute HSV-1-induced encephalitis [<xref ref-type="bibr" rid="B148-viruses-11-00966">148</xref>,<xref ref-type="bibr" rid="B149-viruses-11-00966">149</xref>]. Increased penetrance of HSV-1 into the brain with advanced age may contribute to the development of AD pathology in these regions. In support of this hypothesis, HSV-1 DNA has been identified within amyloid plaques in the brains of AD patients [<xref ref-type="bibr" rid="B150-viruses-11-00966">150</xref>].</p>
<p>The data discussed here provide exciting insights, suggesting that age and HSV-1 infection are associated with AD development. Understanding the relationship between HSV-1 infection and AD pathogenesis may allow for the development or increased usage of anti-viral therapeutics that may aid in either preventing or allaying AD development. However, conflicting data exists that have demonstrated relatively few AD and healthy aged brains containing HSV-1 [<xref ref-type="bibr" rid="B151-viruses-11-00966">151</xref>,<xref ref-type="bibr" rid="B152-viruses-11-00966">152</xref>]. These latter data, combined with other studies demonstrating the presence of HSV-1 in the healthy aged brain [<xref ref-type="bibr" rid="B145-viruses-11-00966">145</xref>,<xref ref-type="bibr" rid="B146-viruses-11-00966">146</xref>], highlight the fact that HSV-1 infection cannot be the sole factor underlying the development of sporadic AD. Rather, complex virus–host interactions are likely occurring that contribute to AD pathogenesis, including ones that may be particular to individual virus strains, human hosts, and environmental factors (<xref ref-type="fig" rid="viruses-11-00966-f001">Figure 1</xref>).</p>
</sec>
<sec id="sec4dot2-viruses-11-00966">
<title>4.2. Implications for HSV-1 Infection in the Development of AD Pathology</title>
<p>The potential molecular mechanisms whereby HSV-1 infection may contribute to AD pathology have been recently reviewed in a comprehensive manner [<xref ref-type="bibr" rid="B26-viruses-11-00966">26</xref>]. Neuronal infection with HSV-1 has been linked to amyloid beta accumulation, hyperphosphorylation of tau, neuroinflammation, and synaptic dysfunction [<xref ref-type="bibr" rid="B26-viruses-11-00966">26</xref>]. Increased amyloid beta expression and accumulation following infection with HSV-1 have been demonstrated in vitro and in vivo, respectively [<xref ref-type="bibr" rid="B26-viruses-11-00966">26</xref>,<xref ref-type="bibr" rid="B34-viruses-11-00966">34</xref>,<xref ref-type="bibr" rid="B153-viruses-11-00966">153</xref>]. This induction in amyloid beta deposition may be the result of an upregulation in the expression of key amyloid beta processing components in response to infection [<xref ref-type="bibr" rid="B153-viruses-11-00966">153</xref>]. In adult hippocampal neural stem cells, amyloid beta protein accumulates in response to HSV-1 infection, leading to decreased proliferation and differentiation both in vitro and in vivo [<xref ref-type="bibr" rid="B154-viruses-11-00966">154</xref>]. These data have important implications for the impacts of recurrent cycles of latency and reactivation on learning and memory loss with age and AD development. Increased expression of the tau phosphorylating enzymes GSK3β and PKA following HSV-1 infection may trigger the tau hyperphosphorylation observed in HSV-1-infected neurons in vitro [<xref ref-type="bibr" rid="B26-viruses-11-00966">26</xref>,<xref ref-type="bibr" rid="B155-viruses-11-00966">155</xref>,<xref ref-type="bibr" rid="B156-viruses-11-00966">156</xref>,<xref ref-type="bibr" rid="B157-viruses-11-00966">157</xref>]. In addition to an upregulation in neuroinflammation [<xref ref-type="bibr" rid="B158-viruses-11-00966">158</xref>,<xref ref-type="bibr" rid="B159-viruses-11-00966">159</xref>,<xref ref-type="bibr" rid="B160-viruses-11-00966">160</xref>], HSV-1 triggers synaptic dysfunction and synapse loss via activation of GSK3β and amyloid beta accumulation [<xref ref-type="bibr" rid="B38-viruses-11-00966">38</xref>]. Alterations in synaptic stability and function may also be an indirect result of the accumulation of hyperphosphorylated tau and aberrant cytoskeletal rearrangement, as well as an off-target consequence of neuroinflammation.</p>
<p>All of the above molecular consequences of HSV-1 infection have also been implicated in the manifestation of cognitive deficits associated with AD. In addition, neuronal infection with HSV-1 triggers a number of different transcriptional changes in host neurons, including alterations in immune response, cell cytoarchitecture, extracellular matrix, and neuronal metabolism [<xref ref-type="bibr" rid="B161-viruses-11-00966">161</xref>]. Over time, these changes in neuronal physiology may adversely affect neuron-neuron and/or neuron-glia signaling, resulting in synaptic dysfunction and aberrant synaptic pruning. Together, these studies link HSV-1 infection with the development of AD pathology in infected neurons.</p>
</sec>
</sec>
<sec id="sec5-viruses-11-00966">
<title>5. Strain-Specific Differences in HSV-1 Neurovirulence and the Potential Impact on AD Development</title>
<p>Recent studies have demonstrated that extensive genetic diversity exists between circulating HSV-1 strains, as well as within the pool of virus (i.e. virions or viral genomes) associated with any one infection [<xref ref-type="bibr" rid="B47-viruses-11-00966">47</xref>,<xref ref-type="bibr" rid="B48-viruses-11-00966">48</xref>,<xref ref-type="bibr" rid="B162-viruses-11-00966">162</xref>]. Other studies have highlighted the impact of specific polymorphisms on differences in pathogenesis and neurovirulence observed between different strains of HSV-1 [<xref ref-type="bibr" rid="B163-viruses-11-00966">163</xref>,<xref ref-type="bibr" rid="B164-viruses-11-00966">164</xref>]. The term neurovirulence is used to describe a virus’s ability to directly impact the nervous system and cause disease [<xref ref-type="bibr" rid="B165-viruses-11-00966">165</xref>]. Neurovirulence is the sum total of multiple underlying components, which include the ability of a given virus strain to invade the nervous system (neuroinvasion), its cell-to-cell spread capabilities, the ability to replicate in neurons and cause overt disease, and its ability to reactivate from latency [<xref ref-type="bibr" rid="B49-viruses-11-00966">49</xref>,<xref ref-type="bibr" rid="B166-viruses-11-00966">166</xref>]. The correlation of specific genetic differences between HSV-1 strains to phenotypic outcomes in viral fitness and neurovirulence is therefore of significant clinical relevance. In different strains of HSV-1, the comparison of viral genotype to disease phenotype has revealed connections between ocular disease and specific viral protein variants [<xref ref-type="bibr" rid="B167-viruses-11-00966">167</xref>]. These data suggest that polymorphisms in specific viral proteins may impact cell-to-cell spread and neurovirulence. Likewise, a recent comparison of fraternal (dizygotic) vs. identical (monozygotic) human twins with HSV-1 infection provided evidence suggesting that differences in oral shedding rate were linked to viral genetic factors, rather than to human differences [<xref ref-type="bibr" rid="B59-viruses-11-00966">59</xref>]. Elucidating the contributions of these variants to HSV-1 pathogenesis has significant implications, not only for understanding the mechanisms of acute disease, but also to understanding the complications of persistent infection to disease occurrence later in life.</p>
<p>In animal models of infection, different strains of HSV-1 possess varying abilities to reach the CNS after inoculation at peripheral sites (<xref ref-type="fig" rid="viruses-11-00966-f004">Figure 4</xref>), suggesting that there are strain-specific differences in neuroinvasion, which is a critical component of neurovirulence [<xref ref-type="bibr" rid="B49-viruses-11-00966">49</xref>,<xref ref-type="bibr" rid="B50-viruses-11-00966">50</xref>,<xref ref-type="bibr" rid="B168-viruses-11-00966">168</xref>]. Importantly, this appears to reflect differences in neuron-to-neuron spread capabilities between strains rather than differences in their ability to infect and replicate in neurons. For instance, coding variations in virion surface glycoproteins have been detected between strains, which have been shown to influence viral entry and intercellular spread [<xref ref-type="bibr" rid="B58-viruses-11-00966">58</xref>,<xref ref-type="bibr" rid="B169-viruses-11-00966">169</xref>,<xref ref-type="bibr" rid="B170-viruses-11-00966">170</xref>]. Other essential components of an HSV-1 strain’s neurovirulence include its ability to cause overt disease and to reactivate from latency [<xref ref-type="bibr" rid="B166-viruses-11-00966">166</xref>]. In rabbit ocular models of HSV-1 infection, inoculation with a commonly used laboratory strain, McKrae, yielded roughly 50% mortality, and a high rate of spontaneous reactivation following latency. In contrast, infection with a different strain, KOS, yielded no mortality and low rates of spontaneous reactivation [<xref ref-type="bibr" rid="B83-viruses-11-00966">83</xref>,<xref ref-type="bibr" rid="B168-viruses-11-00966">168</xref>,<xref ref-type="bibr" rid="B171-viruses-11-00966">171</xref>]. These differences in disease severity and ability to spontaneously reactivate may in part be due to distinct strain-specific polymorphisms within key viral genes such as ICP34.5 and LAT [<xref ref-type="bibr" rid="B170-viruses-11-00966">170</xref>,<xref ref-type="bibr" rid="B171-viruses-11-00966">171</xref>]. As mentioned above, the LATs play key roles in the repression of lytic viral gene expression, as well in controlling reactivation [<xref ref-type="bibr" rid="B33-viruses-11-00966">33</xref>,<xref ref-type="bibr" rid="B77-viruses-11-00966">77</xref>,<xref ref-type="bibr" rid="B78-viruses-11-00966">78</xref>,<xref ref-type="bibr" rid="B79-viruses-11-00966">79</xref>,<xref ref-type="bibr" rid="B80-viruses-11-00966">80</xref>,<xref ref-type="bibr" rid="B81-viruses-11-00966">81</xref>]. Differences in LAT expression or function between strains may impact the virus’s ability to enter and/or maintain latency, resulting in disparities in disease pathogenesis. The viral gene ICP34.5 exhibits variation between HSV-1 strains. ICP34.5 encodes a neurovirulence factor that controls viral protein expression and replication in the nervous system [<xref ref-type="bibr" rid="B172-viruses-11-00966">172</xref>,<xref ref-type="bibr" rid="B173-viruses-11-00966">173</xref>], as well as autophagy in infected neurons [<xref ref-type="bibr" rid="B174-viruses-11-00966">174</xref>]. Importantly, ICP34.5 deletion and truncation mutants demonstrate altered neurovirulence in animal models, as does insertion of ICP34.5 from an avirulent strain into a neurovirulent strain backbone [<xref ref-type="bibr" rid="B171-viruses-11-00966">171</xref>,<xref ref-type="bibr" rid="B172-viruses-11-00966">172</xref>,<xref ref-type="bibr" rid="B174-viruses-11-00966">174</xref>,<xref ref-type="bibr" rid="B175-viruses-11-00966">175</xref>]. Additionally, it has been hypothesized that variations in ICP34.5 coding sequences results in alternative protein localization between strains, and may influence neurovirulence [<xref ref-type="bibr" rid="B176-viruses-11-00966">176</xref>]. Together, these data highlight that polymorphisms within specific viral genes may play important roles in regulating the neurovirulence of a given HSV-1 strain. These genetic differences between virus strains may ultimately have differential impacts on the contributions of persistent HSV-1 infection to the development of AD. Yet to date, most studies of HSV-1 and AD molecular interactions have examined only one strain at a time [<xref ref-type="bibr" rid="B24-viruses-11-00966">24</xref>,<xref ref-type="bibr" rid="B153-viruses-11-00966">153</xref>,<xref ref-type="bibr" rid="B155-viruses-11-00966">155</xref>,<xref ref-type="bibr" rid="B157-viruses-11-00966">157</xref>,<xref ref-type="bibr" rid="B177-viruses-11-00966">177</xref>,<xref ref-type="bibr" rid="B178-viruses-11-00966">178</xref>,<xref ref-type="bibr" rid="B179-viruses-11-00966">179</xref>,<xref ref-type="bibr" rid="B180-viruses-11-00966">180</xref>,<xref ref-type="bibr" rid="B181-viruses-11-00966">181</xref>,<xref ref-type="bibr" rid="B182-viruses-11-00966">182</xref>,<xref ref-type="bibr" rid="B183-viruses-11-00966">183</xref>]. Future research should therefore seek to understand the phenotypic consequences of distinct strain polymorphisms on neurovirulence traits, as well as strain-specific impacts on host neuronal physiology and potential AD-related neuropathology over time.</p>
<p>It is important to note that host-specific factors also play key roles in the regulation of HSV-1 neurovirulence. Not all individuals who are infected with HSV-1 develop AD, nor do all patients with evidence of CNS dissemination of HSV-1 develop AD [<xref ref-type="bibr" rid="B144-viruses-11-00966">144</xref>]. There may be both virus- and host-specific factors that trigger differences in host immune responses and/or susceptibility to virus-induced neuronal damage. For instance, viral strain differences in replication or reactivation rate may manifest as differences in lesion intensity of frequency of reactivation. In addition, differences in human immune detection (intrinsic cell defenses) and/or adaptive immune responses may lead to variations in the efficacy of immune control and thus the duration of periods of latency. HSV-1-encoded glycoproteins, gE and gI, together form a heterodimer that functions as an Fc gamma receptor (FcγR) and binds to host immunoglobulin (IgG), contributing to immune evasion [<xref ref-type="bibr" rid="B184-viruses-11-00966">184</xref>,<xref ref-type="bibr" rid="B185-viruses-11-00966">185</xref>]. The HSV-1 FcγR demonstrates specificity in binding to different IgG1 allotypes [<xref ref-type="bibr" rid="B186-viruses-11-00966">186</xref>], suggesting that variability may exist between individuals in their ability to mount effective immune responses against both lytic and latent HSV-1 infection [<xref ref-type="bibr" rid="B187-viruses-11-00966">187</xref>]. Over time, virus strain- and host-specific interactions such as these may cause different degrees of parainflammation between patients, resulting in differential impacts on the probability of AD development later in life. In support of this hypothesis, associations between mild cognitive impairment, AD, and anti-HSV-1 antibody levels were recently found to vary dependent on immunoglobulin gamma marker genotype [<xref ref-type="bibr" rid="B188-viruses-11-00966">188</xref>].</p>
<p>Genetic differences in anti-HSV-1 immune responses, compounded by infection with more neurovirulent strains of HSV-1, may exacerbate the development of cognitive deficits with age. Additionally, infection with a highly neurovirulent strain of HSV-1 combined with a genetic predisposition for AD development may also increase an individual’s’ risk, as previously hypothesized [<xref ref-type="bibr" rid="B189-viruses-11-00966">189</xref>]. This is supported by evidence identifying specific host genetic loci that influence HSV-1 disease pathogenesis [<xref ref-type="bibr" rid="B52-viruses-11-00966">52</xref>]. One specific example is carriage of the apolipoprotein E ε4 (APOE4) allele, a known genetic risk factor for the development of AD [<xref ref-type="bibr" rid="B190-viruses-11-00966">190</xref>,<xref ref-type="bibr" rid="B191-viruses-11-00966">191</xref>]. Recent data has shown a positive association between HSV-1 infection, carriage of the APOE4 allele, and declining episodic memory function in elderly individuals [<xref ref-type="bibr" rid="B192-viruses-11-00966">192</xref>]. The apoE4 isoform has been hypothesized to facilitate HSV-1 entry and latency in the brain more readily than other apolipoprotein isoforms [<xref ref-type="bibr" rid="B193-viruses-11-00966">193</xref>,<xref ref-type="bibr" rid="B194-viruses-11-00966">194</xref>]. Relative neurovirulence of any particular HSV-1 strain may therefore be compounded with a host’s genetic predisposition for AD, such as carriage of the APOE4 allele, resulting in more rapid and/or more advanced disease development. However, further analyses need to be done to assess the relationship between HSV-1 strain and APOE4 allele variation.</p>
<p>The connection between neuronal HSV-1 infection and the accumulation of amyloid beta and hyperphosphorylated tau are clear [see references above and reviewed in [<xref ref-type="bibr" rid="B26-viruses-11-00966">26</xref>]]. To date, no studies have been performed examining whether there are virus strain-specific differences in the generation and accumulation of these neurotoxic proteins, and how variation between individual hosts also contributes to these pathologies. Future studies should aim to identify and investigate how variations between specific hosts and virus strains lead to differences in observed HSV-1 neurovirulence, how these impact neuronal physiology over time, and the contributions of these factors to disease development. Targeted antiviral therapies can then be used in a way that matches the specific therapeutic approach to the precise pathogen strain present and the host’s own ability to control that virus strain. In this way, the development of AD pathology and cognitive dysfunction can be potentially slowed or inhibited.</p>
</sec>
<sec id="sec6-viruses-11-00966" sec-type="conclusions">
<title>6. Conclusions</title>
<p>The etiology of sporadic AD is complex, and is hypothesized to involve both environmental and genetic factors. It is becoming increasingly clear that persistent infection by microbes such as HSV-1 may play important roles in the development of sporadic AD. Our understanding of the association between neuronal infection with HSV-1 and AD is just beginning to surface. Repeated cycles of HSV-1 latency and reactivation may trigger chronic central and/or peripheral parainflammation, which over time causes synapse loss, potentially leading to the cognitive deficits associated with AD. Additionally, neuronal infection with HSV-1 may contribute to the accumulation of amyloid beta deposits and hyperphosphorylated tau that are associated with AD pathology. Together, these characteristics of HSV-1 infection may increase the risk of developing sporadic AD. More research is needed to definitively understand the molecular mechanisms of how virus strain- and host-specific factors intersect to impact disease pathology and development. Understanding the specificity and individualized nature of these lifelong host-virus interactions may lead to the identification of novel therapeutic opportunities to prevent or slow the progression of AD.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>The authors would like to acknowledge invaluable support from members of the laboratories of David Hughes and Moriah Szpara at the Pennsylvania State University. Additionally, we would like to acknowledge the instrumental training and guidance received by C.A.M. from Willard Freeman at the University of Oklahoma Health Sciences Center.</p>
</ack>
<notes>
<title>Author Contributions</title>
<p>Conceptualization, C.A.M. and M.L.S.; writing—original draft preparation, C.A.M.; writing—review and editing, C.A.M. and M.L.S.; funding acquisition, M.L.S.</p>
</notes>
<notes>
<title>Funding</title>
<p>This research was funded, in part, by a grant from the National Institutes of Health (NIH) R01 AI132692 (M.L.S.) and by a grant from the Pennsylvania Department of Health Commonwealth Universal Research Enhancement (CURE) program (M.L.S.). The Department specifically disclaims responsibility for any analyses, interpretations, or conclusions. C.A.M. acknowledges prior fellowship funding from the American Heart Association (16POST29920001).</p>
</notes>
<notes notes-type="COI-statement">
<title>Conflicts of Interest</title>
<p>The authors declare no conflict of interest.</p>
</notes>
<ref-list>
<title>References</title>
<ref id="B1-viruses-11-00966">
<label>1.</label>
<element-citation publication-type="web">
<article-title>World Population Prospects—Population Division—United Nations</article-title>
<comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://population.un.org/wpp/">https://population.un.org/wpp/</ext-link></comment>
<date-in-citation content-type="access-date" iso-8601-date="2019-10-19">(accessed on 19 October 2019)</date-in-citation>
</element-citation>
</ref>
<ref id="B2-viruses-11-00966">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Elobeid</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Libard</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Leino</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Popova</surname>
<given-names>S.N.</given-names>
</name>
<name>
<surname>Alafuzoff</surname>
<given-names>I.</given-names>
</name>
</person-group>
<article-title>Altered Proteins in the Aging Brain</article-title>
<source/>J. Neuropathol. Exp. Neurol.
          <year>2016</year>
<volume>75</volume>
<fpage>316</fpage>
<lpage>325</lpage>
<pub-id pub-id-type="doi">10.1093/jnen/nlw002</pub-id>
<pub-id pub-id-type="pmid">26979082</pub-id>
</element-citation>
</ref>
<ref id="B3-viruses-11-00966">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mrak</surname>
<given-names>R.E.</given-names>
</name>
<name>
<surname>Griffin</surname>
<given-names>S.T.</given-names>
</name>
<name>
<surname>Graham</surname>
<given-names>D.I.</given-names>
</name>
</person-group>
<article-title>Aging-associated changes in human brain</article-title>
<source/>J. Neuropathol. Exp. Neurol.
          <year>1997</year>
<volume>56</volume>
<fpage>1269</fpage>
<lpage>1275</lpage>
<pub-id pub-id-type="doi">10.1097/00005072-199712000-00001</pub-id>
<pub-id pub-id-type="pmid">9413275</pub-id>
</element-citation>
</ref>
<ref id="B4-viruses-11-00966">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Franceschi</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Bonafè</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Valensin</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Olivieri</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Luca</surname>
<given-names>M.D.</given-names>
</name>
<name>
<surname>Ottaviani</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Benedictis</surname>
<given-names>G.D.</given-names>
</name>
</person-group>
<article-title>Inflamm-aging: An Evolutionary Perspective on Immunosenescence</article-title>
<source/>Ann. N. Y. Acad. Sci.
          <year>2000</year>
<volume>908</volume>
<fpage>244</fpage>
<lpage>254</lpage>
<pub-id pub-id-type="doi">10.1111/j.1749-6632.2000.tb06651.x</pub-id>
<pub-id pub-id-type="pmid">10911963</pub-id>
</element-citation>
</ref>
<ref id="B5-viruses-11-00966">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heneka</surname>
<given-names>M.T.</given-names>
</name>
<name>
<surname>Carson</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>El Khoury</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Landreth</surname>
<given-names>G.E.</given-names>
</name>
<name>
<surname>Brosseron</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Feinstein</surname>
<given-names>D.L.</given-names>
</name>
<name>
<surname>Jacobs</surname>
<given-names>A.H.</given-names>
</name>
<name>
<surname>Wyss-Coray</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Vitorica</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ransohoff</surname>
<given-names>R.M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Neuroinflammation in Alzheimer’s disease</article-title>
<source/>Lancet Neurol.
          <year>2015</year>
<volume>14</volume>
<fpage>388</fpage>
<lpage>405</lpage>
<pub-id pub-id-type="doi">10.1016/S1474-4422(15)70016-5</pub-id>
<pub-id pub-id-type="pmid">25792098</pub-id>
</element-citation>
</ref>
<ref id="B6-viruses-11-00966">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lucin</surname>
<given-names>K.M.</given-names>
</name>
<name>
<surname>Wyss-Coray</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Immune activation in brain aging and neurodegeneration: Too much or too little?</article-title>
<source/>Neuron
          <year>2009</year>
<volume>64</volume>
<fpage>110</fpage>
<lpage>122</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2009.08.039</pub-id>
<pub-id pub-id-type="pmid">19840553</pub-id>
</element-citation>
</ref>
<ref id="B7-viruses-11-00966">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nichols</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Szoeke</surname>
<given-names>C.E.I.</given-names>
</name>
<name>
<surname>Vollset</surname>
<given-names>S.E.</given-names>
</name>
<name>
<surname>Abbasi</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Abd-Allah</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Abdela</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Aichour</surname>
<given-names>M.T.E.</given-names>
</name>
<name>
<surname>Akinyemi</surname>
<given-names>R.O.</given-names>
</name>
<name>
<surname>Alahdab</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Asgedom</surname>
<given-names>S.W.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Global, regional, and national burden of Alzheimer’s disease and other dementias, 1990–2016: A systematic analysis for the Global Burden of Disease Study Lancet Neurol. 2019, 18, 88–106</article-title>
<source/>Lancet Neurol.
          <year>2019</year>
<volume>18</volume>
<fpage>88</fpage>
<lpage>106</lpage>
<pub-id pub-id-type="doi">10.1016/S1474-4422(18)30403-4</pub-id>
<pub-id pub-id-type="pmid">30497964</pub-id>
</element-citation>
</ref>
<ref id="B8-viruses-11-00966">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pinto</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Lanctôt</surname>
<given-names>K.L.</given-names>
</name>
<name>
<surname>Herrmann</surname>
<given-names>N.</given-names>
</name>
</person-group>
<article-title>Revisiting the cholinergic hypothesis of behavioral and psychological symptoms in dementia of the Alzheimer’s type</article-title>
<source/>Ageing Res. Rev.
          <year>2011</year>
<volume>10</volume>
<fpage>404</fpage>
<lpage>412</lpage>
<pub-id pub-id-type="doi">10.1016/j.arr.2011.01.003</pub-id>
<pub-id pub-id-type="pmid">21292041</pub-id>
</element-citation>
</ref>
<ref id="B9-viruses-11-00966">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ray</surname>
<given-names>W.J.</given-names>
</name>
<name>
<surname>Ashall</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Goate DPhil</surname>
<given-names>A.M.</given-names>
</name>
</person-group>
<article-title>Molecular pathogenesis of sporadic and familial forms of Alzheimer’s disease</article-title>
<source/>Mol. Med. Today
          <year>1998</year>
<volume>4</volume>
<fpage>151</fpage>
<lpage>157</lpage>
<pub-id pub-id-type="doi">10.1016/S1357-4310(98)01229-5</pub-id>
<pub-id pub-id-type="pmid">9572056</pub-id>
</element-citation>
</ref>
<ref id="B10-viruses-11-00966">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Menéndez</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Pathological and clinical heterogeneity of presenilin 1 gene mutations</article-title>
<source/>J. Alzheimers Dis.
          <year>2004</year>
<volume>6</volume>
<fpage>475</fpage>
<lpage>482</lpage>
<pub-id pub-id-type="doi">10.3233/JAD-2004-6503</pub-id>
<pub-id pub-id-type="pmid">15505368</pub-id>
</element-citation>
</ref>
<ref id="B11-viruses-11-00966">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gómez-Isla</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Growdon</surname>
<given-names>W.B.</given-names>
</name>
<name>
<surname>McNamara</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Nochlin</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Bird</surname>
<given-names>T.D.</given-names>
</name>
<name>
<surname>Arango</surname>
<given-names>J.C.</given-names>
</name>
<name>
<surname>Lopera</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Kosik</surname>
<given-names>K.S.</given-names>
</name>
<name>
<surname>Lantos</surname>
<given-names>P.L.</given-names>
</name>
<name>
<surname>Cairns</surname>
<given-names>N.J.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The impact of different presenilin 1 and presenilin 2 mutations on amyloid deposition, neurofibrillary changes and neuronal loss in the familial Alzheimer’s disease brainEvidence for other phenotype-modifying factors</article-title>
<source/>Brain
          <year>1999</year>
<volume>122</volume>
<fpage>1709</fpage>
<lpage>1719</lpage>
<pub-id pub-id-type="doi">10.1093/brain/122.9.1709</pub-id>
<pub-id pub-id-type="pmid">10468510</pub-id>
</element-citation>
</ref>
<ref id="B12-viruses-11-00966">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cruts</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>van Duijn</surname>
<given-names>C.M.</given-names>
</name>
<name>
<surname>Backhovens</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Van den Broeck</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wehnert</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Serneels</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sherrington</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Hutton</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hardy</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>St George-Hyslop</surname>
<given-names>P.H.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Estimation of the genetic contribution of presenilin-1 and -2 mutations in a population-based study of presenile Alzheimer disease</article-title>
<source/>Hum. Mol. Genet.
          <year>1998</year>
<volume>7</volume>
<fpage>43</fpage>
<lpage>51</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/7.1.43</pub-id>
<pub-id pub-id-type="pmid">9384602</pub-id>
</element-citation>
</ref>
<ref id="B13-viruses-11-00966">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lippa</surname>
<given-names>C.F.</given-names>
</name>
<name>
<surname>Saunders</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>T.W.</given-names>
</name>
<name>
<surname>Swearer</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Drachman</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Ghetti</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Nee</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Pulaski-Salo</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Dickson</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Robitaille</surname>
<given-names>Y.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Familial and sporadic Alzheimer’s disease</article-title>
<source/>Neurology
          <year>1996</year>
<volume>46</volume>
<fpage>406</fpage>
<pub-id pub-id-type="doi">10.1212/WNL.46.2.406</pub-id>
<pub-id pub-id-type="pmid">8614503</pub-id>
</element-citation>
</ref>
<ref id="B14-viruses-11-00966">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goate</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Segregation of a missense mutation in the amyloid beta-protein precursor gene with familial Alzheimer’s disease</article-title>
<source/>J. Alzheimers Dis.
          <year>2006</year>
<volume>9</volume>
<fpage>341</fpage>
<lpage>347</lpage>
<pub-id pub-id-type="doi">10.3233/JAD-2006-9S338</pub-id>
<pub-id pub-id-type="pmid">16914872</pub-id>
</element-citation>
</ref>
<ref id="B15-viruses-11-00966">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hellström-Lindahl</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Viitanen</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Marutle</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Comparison of Aβ levels in the brain of familial and sporadic Alzheimer’s disease</article-title>
<source/>Neurochem. Int.
          <year>2009</year>
<volume>55</volume>
<fpage>243</fpage>
<lpage>252</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuint.2009.03.007</pub-id>
<pub-id pub-id-type="pmid">19524115</pub-id>
</element-citation>
</ref>
<ref id="B16-viruses-11-00966">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rogaev</surname>
<given-names>E.I.</given-names>
</name>
<name>
<surname>Sherrington</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Rogaeva</surname>
<given-names>E.A.</given-names>
</name>
<name>
<surname>Levesque</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Ikeda</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Chi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Holman</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Tsuda</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Familial Alzheimer’s disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer’s disease type 3 gene</article-title>
<source/>Nature
          <year>1995</year>
<volume>376</volume>
<fpage>775</fpage>
<lpage>778</lpage>
<pub-id pub-id-type="doi">10.1038/376775a0</pub-id>
<pub-id pub-id-type="pmid">7651536</pub-id>
</element-citation>
</ref>
<ref id="B17-viruses-11-00966">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>H.-C.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>Z.-F.</given-names>
</name>
</person-group>
<article-title>Accumulated amyloid-beta peptide and hyperphosphorylated tau protein: Relationship and links in Alzheimer’s disease</article-title>
<source/>J. Alzheimers Dis.
          <year>2009</year>
<volume>16</volume>
<fpage>15</fpage>
<lpage>27</lpage>
<pub-id pub-id-type="doi">10.3233/JAD-2009-0960</pub-id>
<pub-id pub-id-type="pmid">19158417</pub-id>
</element-citation>
</ref>
<ref id="B18-viruses-11-00966">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wyss-Coray</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Rogers</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Inflammation in Alzheimer Disease—A Brief Review of the Basic Science and Clinical Literature</article-title>
<source/>Cold Spring Harb. Perspect Med.
          <year>2012</year>
<volume>2</volume>
<fpage>a006346</fpage>
<pub-id pub-id-type="doi">10.1101/cshperspect.a006346</pub-id>
<pub-id pub-id-type="pmid">22315714</pub-id>
</element-citation>
</ref>
<ref id="B19-viruses-11-00966">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Chiara</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Marcocci</surname>
<given-names>M.E.</given-names>
</name>
<name>
<surname>Sgarbanti</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Civitelli</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Ripoli</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Piacentini</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Garaci</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Grassi</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Palamara</surname>
<given-names>A.T.</given-names>
</name>
</person-group>
<article-title>Infectious Agents and Neurodegeneration</article-title>
<source/>Mol. Neurobiol.
          <year>2012</year>
<volume>46</volume>
<fpage>614</fpage>
<lpage>638</lpage>
<pub-id pub-id-type="doi">10.1007/s12035-012-8320-7</pub-id>
<pub-id pub-id-type="pmid">22899188</pub-id>
</element-citation>
</ref>
<ref id="B20-viruses-11-00966">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dehhaghi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kazemi Shariat Panahi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Guillemin</surname>
<given-names>G.J.</given-names>
</name>
</person-group>
<article-title>Microorganisms’ Footprint in Neurodegenerative Diseases</article-title>
<source/>Front. Cell Neurosci.
          <year>2018</year>
<volume>12</volume>
<fpage>466</fpage>
<pub-id pub-id-type="doi">10.3389/fncel.2018.00466</pub-id>
<pub-id pub-id-type="pmid">30564101</pub-id>
</element-citation>
</ref>
<ref id="B21-viruses-11-00966">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gosztyla</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>Brothers</surname>
<given-names>H.M.</given-names>
</name>
<name>
<surname>Robinson</surname>
<given-names>S.R.</given-names>
</name>
</person-group>
<article-title>Alzheimer’s Amyloid-β is an Antimicrobial Peptide: A Review of the Evidence</article-title>
<source/>J. Alzheimer’s Dis.
          <year>2018</year>
<volume>62</volume>
<fpage>1495</fpage>
<lpage>1506</lpage>
<pub-id pub-id-type="doi">10.3233/JAD-171133</pub-id>
<pub-id pub-id-type="pmid">29504537</pub-id>
</element-citation>
</ref>
<ref id="B22-viruses-11-00966">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moir</surname>
<given-names>R.D.</given-names>
</name>
<name>
<surname>Lathe</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Tanzi</surname>
<given-names>R.E.</given-names>
</name>
</person-group>
<article-title>The antimicrobial protection hypothesis of Alzheimer’s disease</article-title>
<source/>Alzheimer’s Dement. J. Alzheimer’s Assoc.
          <year>2018</year>
<volume>14</volume>
<fpage>1602</fpage>
<lpage>1614</lpage>
<pub-id pub-id-type="doi">10.1016/j.jalz.2018.06.3040</pub-id>
<pub-id pub-id-type="pmid">30314800</pub-id>
</element-citation>
</ref>
<ref id="B23-viruses-11-00966">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sochocka</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zwolińska</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Leszek</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>The Infectious Etiology of Alzheimer’s Disease</article-title>
<source/>Curr. Neuropharmacol.
          <year>2017</year>
<volume>15</volume>
<fpage>996</fpage>
<lpage>1009</lpage>
<pub-id pub-id-type="doi">10.2174/1570159X15666170313122937</pub-id>
<pub-id pub-id-type="pmid">28294067</pub-id>
</element-citation>
</ref>
<ref id="B24-viruses-11-00966">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Chiara</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Piacentini</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Fabiani</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mastrodonato</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Marcocci</surname>
<given-names>M.E.</given-names>
</name>
<name>
<surname>Limongi</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Napoletani</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Protto</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Coluccio</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Celestino</surname>
<given-names>I.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Recurrent herpes simplex virus-1 infection induces hallmarks of neurodegeneration and cognitive deficits in mice</article-title>
<source/>PLoS Pathog.
          <year>2019</year>
<volume>15</volume>
<elocation-id>e1007617</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.ppat.1007617</pub-id>
<pub-id pub-id-type="pmid">30870531</pub-id>
</element-citation>
</ref>
<ref id="B25-viruses-11-00966">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dickerson</surname>
<given-names>F.B.</given-names>
</name>
<name>
<surname>Boronow</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Stallings</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Origoni</surname>
<given-names>A.E.</given-names>
</name>
<name>
<surname>Ruslanova</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Yolken</surname>
<given-names>R.H.</given-names>
</name>
</person-group>
<article-title>Association of serum antibodies to herpes simplex virus 1 with cognitive deficits in individuals with schizophrenia</article-title>
<source/>Arch. Gen. Psychiatry
          <year>2003</year>
<volume>60</volume>
<fpage>466</fpage>
<lpage>472</lpage>
<pub-id pub-id-type="doi">10.1001/archpsyc.60.5.466</pub-id>
<pub-id pub-id-type="pmid">12742867</pub-id>
</element-citation>
</ref>
<ref id="B26-viruses-11-00966">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Harris</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>Harris</surname>
<given-names>E.A.</given-names>
</name>
</person-group>
<article-title>Molecular Mechanisms for Herpes Simplex Virus Type 1 Pathogenesis in Alzheimer’s Disease</article-title>
<source/>Front. Aging Neurosci.
          <year>2018</year>
<volume>10</volume>
<fpage>48</fpage>
<pub-id pub-id-type="doi">10.3389/fnagi.2018.00048</pub-id>
<pub-id pub-id-type="pmid">29559905</pub-id>
</element-citation>
</ref>
<ref id="B27-viruses-11-00966">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Prasad</surname>
<given-names>K.M.</given-names>
</name>
<name>
<surname>Watson</surname>
<given-names>A.M.M.</given-names>
</name>
<name>
<surname>Dickerson</surname>
<given-names>F.B.</given-names>
</name>
<name>
<surname>Yolken</surname>
<given-names>R.H.</given-names>
</name>
<name>
<surname>Nimgaonkar</surname>
<given-names>V.L.</given-names>
</name>
</person-group>
<article-title>Exposure to herpes simplex virus type 1 and cognitive impairments in individuals with schizophrenia</article-title>
<source/>Schizophr. Bull.
          <year>2012</year>
<volume>38</volume>
<fpage>1137</fpage>
<lpage>1148</lpage>
<pub-id pub-id-type="doi">10.1093/schbul/sbs046</pub-id>
<pub-id pub-id-type="pmid">22490995</pub-id>
</element-citation>
</ref>
<ref id="B28-viruses-11-00966">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Looker</surname>
<given-names>K.J.</given-names>
</name>
<name>
<surname>Magaret</surname>
<given-names>A.S.</given-names>
</name>
<name>
<surname>May</surname>
<given-names>M.T.</given-names>
</name>
<name>
<surname>Turner</surname>
<given-names>K.M.E.</given-names>
</name>
<name>
<surname>Vickerman</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Gottlieb</surname>
<given-names>S.L.</given-names>
</name>
<name>
<surname>Newman</surname>
<given-names>L.M.</given-names>
</name>
</person-group>
<article-title>Global and regional estimates of prevalent and incident herpes simplex virus type 1 infections in 2012</article-title>
<source/>PLoS ONE
          <year>2015</year>
<volume>10</volume>
<elocation-id>e0140765</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0140765</pub-id>
<pub-id pub-id-type="pmid">26510007</pub-id>
</element-citation>
</ref>
<ref id="B29-viruses-11-00966">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Corey</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Spear</surname>
<given-names>P.G.</given-names>
</name>
</person-group>
<article-title>Infections with Herpes Simplex Viruses (Second of Two Parts)</article-title>
<source/>N. Engl. J. Med.
          <year>1986</year>
<volume>314</volume>
<fpage>749</fpage>
<lpage>757</lpage>
<pub-id pub-id-type="doi">10.1056/NEJM198603203141205</pub-id>
<pub-id pub-id-type="pmid">3005859</pub-id>
</element-citation>
</ref>
<ref id="B30-viruses-11-00966">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Looker</surname>
<given-names>K.J.</given-names>
</name>
<name>
<surname>Magaret</surname>
<given-names>A.S.</given-names>
</name>
<name>
<surname>May</surname>
<given-names>M.T.</given-names>
</name>
<name>
<surname>Turner</surname>
<given-names>K.M.</given-names>
</name>
<name>
<surname>Vickerman</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Newman</surname>
<given-names>L.M.</given-names>
</name>
<name>
<surname>Gottlieb</surname>
<given-names>S.L.</given-names>
</name>
</person-group>
<article-title>First estimates of the global and regional incidence of neonatal herpes infection</article-title>
<source/>Lancet Glob. Health
          <year>2017</year>
<volume>5</volume>
<fpage>e300</fpage>
<lpage>e309</lpage>
<pub-id pub-id-type="doi">10.1016/S2214-109X(16)30362-X</pub-id>
<pub-id pub-id-type="pmid">28153513</pub-id>
</element-citation>
</ref>
<ref id="B31-viruses-11-00966">
<label>31.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Roizman</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Knipe</surname>
<given-names>D.M.</given-names>
</name>
<name>
<surname>Whitley</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Herpes Simplex Viruses</article-title>
<source/>Fields Virology
          <person-group person-group-type="editor">
<name>
<surname>Knipe</surname>
<given-names>D.M.</given-names>
</name>
<name>
<surname>Howley</surname>
<given-names>P.M.</given-names>
</name>
</person-group>
<publisher-name>Lippincott Williams &amp; Wilkins</publisher-name>
<publisher-loc>Philadelphia, PA, USA</publisher-loc>
<year>2013</year>
<volume>Volume 2</volume>
<fpage>1823</fpage>
<lpage>1897</lpage>
</element-citation>
</ref>
<ref id="B32-viruses-11-00966">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deshmane</surname>
<given-names>S.L.</given-names>
</name>
<name>
<surname>Fraser</surname>
<given-names>N.W.</given-names>
</name>
</person-group>
<article-title>During latency, herpes simplex virus type 1 DNA is associated with nucleosomes in a chromatin structure</article-title>
<source/>J. Virol.
          <year>1989</year>
<volume>63</volume>
<fpage>943</fpage>
<lpage>947</lpage>
<pub-id pub-id-type="pmid">2536115</pub-id>
</element-citation>
</ref>
<ref id="B33-viruses-11-00966">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nicoll</surname>
<given-names>M.P.</given-names>
</name>
<name>
<surname>Proença</surname>
<given-names>J.T.</given-names>
</name>
<name>
<surname>Efstathiou</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>The molecular basis of herpes simplex virus latency</article-title>
<source/>FEMS Microbiol. Rev.
          <year>2012</year>
<volume>36</volume>
<fpage>684</fpage>
<lpage>705</lpage>
<pub-id pub-id-type="doi">10.1111/j.1574-6976.2011.00320.x</pub-id>
<pub-id pub-id-type="pmid">22150699</pub-id>
</element-citation>
</ref>
<ref id="B34-viruses-11-00966">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Chiara</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Marcocci</surname>
<given-names>M.E.</given-names>
</name>
<name>
<surname>Civitelli</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Argnani</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Piacentini</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Ripoli</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Manservigi</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Grassi</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Garaci</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Palamara</surname>
<given-names>A.T.</given-names>
</name>
</person-group>
<article-title>APP Processing Induced by Herpes Simplex Virus Type 1 (HSV-1) Yields Several APP Fragments in Human and Rat Neuronal Cells</article-title>
<source/>PLoS ONE
          <year>2010</year>
<volume>5</volume>
<elocation-id>e13989</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0013989</pub-id>
<pub-id pub-id-type="pmid">21085580</pub-id>
</element-citation>
</ref>
<ref id="B35-viruses-11-00966">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lövheim</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Gilthorpe</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Johansson</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Eriksson</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hallmans</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Elgh</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Herpes simplex infection and the risk of Alzheimer’s disease: A nested case-control study</article-title>
<source/>Alzheimers Dement.
          <year>2015</year>
<volume>11</volume>
<fpage>587</fpage>
<lpage>592</lpage>
<pub-id pub-id-type="doi">10.1016/j.jalz.2014.07.157</pub-id>
<pub-id pub-id-type="pmid">25304990</pub-id>
</element-citation>
</ref>
<ref id="B36-viruses-11-00966">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lövheim</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Gilthorpe</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Adolfsson</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Nilsson</surname>
<given-names>L.-G.</given-names>
</name>
<name>
<surname>Elgh</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Reactivated herpes simplex infection increases the risk of Alzheimer’s disease</article-title>
<source/>Alzheimers Dement.
          <year>2015</year>
<volume>11</volume>
<fpage>593</fpage>
<lpage>599</lpage>
<pub-id pub-id-type="doi">10.1016/j.jalz.2014.04.522</pub-id>
<pub-id pub-id-type="pmid">25043910</pub-id>
</element-citation>
</ref>
<ref id="B37-viruses-11-00966">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Piacentini</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>De Chiara</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Li Puma</surname>
<given-names>D.D.</given-names>
</name>
<name>
<surname>Ripoli</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Marcocci</surname>
<given-names>M.E.</given-names>
</name>
<name>
<surname>Garaci</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Palamara</surname>
<given-names>A.T.</given-names>
</name>
<name>
<surname>Grassi</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>HSV-1 and Alzheimer’s disease: More than a hypothesis</article-title>
<source/>Front. Pharmacol.
          <year>2014</year>
<volume>5</volume>
<fpage>1</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.3389/fphar.2014.00097</pub-id>
<pub-id pub-id-type="pmid">24478702</pub-id>
</element-citation>
</ref>
<ref id="B38-viruses-11-00966">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Piacentini</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Puma</surname>
<given-names>D.D.L.</given-names>
</name>
<name>
<surname>Ripoli</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Marcocci</surname>
<given-names>M.E.</given-names>
</name>
<name>
<surname>Chiara</surname>
<given-names>G.D.</given-names>
</name>
<name>
<surname>Garaci</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Palamara</surname>
<given-names>A.T.</given-names>
</name>
<name>
<surname>Grassi</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Herpes Simplex Virus type-1 infection induces synaptic dysfunction in cultured cortical neurons via GSK-3 activation and intraneuronal amyloid-β protein accumulation</article-title>
<source/>Sci. Rep.
          <year>2015</year>
<volume>5</volume>
<fpage>15444</fpage>
<pub-id pub-id-type="doi">10.1038/srep15444</pub-id>
<pub-id pub-id-type="pmid">26487282</pub-id>
</element-citation>
</ref>
<ref id="B39-viruses-11-00966">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Readhead</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Haure-Mirande</surname>
<given-names>J.-V.</given-names>
</name>
<name>
<surname>Funk</surname>
<given-names>C.C.</given-names>
</name>
<name>
<surname>Richards</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Shannon</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Haroutunian</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Sano</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>W.S.</given-names>
</name>
<name>
<surname>Beckmann</surname>
<given-names>N.D.</given-names>
</name>
<name>
<surname>Price</surname>
<given-names>N.D.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Multiscale Analysis of Independent Alzheimer’s Cohorts Finds Disruption of Molecular, Genetic, and Clinical Networks by Human Herpesvirus</article-title>
<source/>Neuron
          <year>2018</year>
<volume>99</volume>
<fpage>64</fpage>
<lpage>82.e7</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2018.05.023</pub-id>
<pub-id pub-id-type="pmid">29937276</pub-id>
</element-citation>
</ref>
<ref id="B40-viruses-11-00966">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bu</surname>
<given-names>X.L.</given-names>
</name>
<name>
<surname>Yao</surname>
<given-names>X.Q.</given-names>
</name>
<name>
<surname>Jiao</surname>
<given-names>S.S.</given-names>
</name>
<name>
<surname>Zeng</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.H.</given-names>
</name>
<name>
<surname>Xiang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>C.R.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Q.H.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>H.Y.</given-names>
</name>
<name>
<surname>Yi</surname>
<given-names>X.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A Study on the Association Between Infectious Burden and Alzheimer’s Disease</article-title>
<source/>Eur. J. Neurol.
          <year>2015</year>
<volume>22</volume>
<fpage>1519</fpage>
<lpage>1525</lpage>
<pub-id pub-id-type="doi">10.1111/ene.12477</pub-id>
<pub-id pub-id-type="pmid">24910016</pub-id>
</element-citation>
</ref>
<ref id="B41-viruses-11-00966">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tzeng</surname>
<given-names>N.-S.</given-names>
</name>
<name>
<surname>Chung</surname>
<given-names>C.-H.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>F.-H.</given-names>
</name>
<name>
<surname>Chiang</surname>
<given-names>C.-P.</given-names>
</name>
<name>
<surname>Yeh</surname>
<given-names>C.-B.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>S.-Y.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>R.-B.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>H.-A.</given-names>
</name>
<name>
<surname>Kao</surname>
<given-names>Y.-C.</given-names>
</name>
<name>
<surname>Yeh</surname>
<given-names>H.-W.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Anti-herpetic Medications and Reduced Risk of Dementia in Patients with Herpes Simplex Virus Infections—A Nationwide, Population-Based Cohort Study in Taiwan</article-title>
<source/>Neurotherapeutics
          <year>2018</year>
<volume>15</volume>
<fpage>417</fpage>
<lpage>429</lpage>
<pub-id pub-id-type="doi">10.1007/s13311-018-0611-x</pub-id>
<pub-id pub-id-type="pmid">29488144</pub-id>
</element-citation>
</ref>
<ref id="B42-viruses-11-00966">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bowen</surname>
<given-names>C.D.</given-names>
</name>
<name>
<surname>Renner</surname>
<given-names>D.W.</given-names>
</name>
<name>
<surname>Shreve</surname>
<given-names>J.T.</given-names>
</name>
<name>
<surname>Tafuri</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Payne</surname>
<given-names>K.M.</given-names>
</name>
<name>
<surname>Dix</surname>
<given-names>R.D.</given-names>
</name>
<name>
<surname>Kinchington</surname>
<given-names>P.R.</given-names>
</name>
<name>
<surname>Gatherer</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Szpara</surname>
<given-names>M.L.</given-names>
</name>
</person-group>
<article-title>Viral forensic genomics reveals the relatedness of classic herpes simplex virus strains KOS, KOS63, and KOS</article-title>
<source/>Virology
          <year>2016</year>
<volume>492</volume>
<fpage>179</fpage>
<lpage>186</lpage>
<pub-id pub-id-type="doi">10.1016/j.virol.2016.02.013</pub-id>
<pub-id pub-id-type="pmid">26950505</pub-id>
</element-citation>
</ref>
<ref id="B43-viruses-11-00966">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kolb</surname>
<given-names>A.W.</given-names>
</name>
<name>
<surname>Adams</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Cabot</surname>
<given-names>E.L.</given-names>
</name>
<name>
<surname>Craven</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Brandt</surname>
<given-names>C.R.</given-names>
</name>
</person-group>
<article-title>Multiplex sequencing of seven ocular herpes simplex virus type-1 genomes: Phylogeny, sequence variability, and SNP distribution</article-title>
<source/>Investig. Ophthalmol. Vis. Sci.
          <year>2011</year>
<volume>52</volume>
<fpage>9061</fpage>
<lpage>9073</lpage>
<pub-id pub-id-type="doi">10.1167/iovs.11-7812</pub-id>
<pub-id pub-id-type="pmid">22016062</pub-id>
</element-citation>
</ref>
<ref id="B44-viruses-11-00966">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Parsons</surname>
<given-names>L.R.</given-names>
</name>
<name>
<surname>Tafuri</surname>
<given-names>Y.R.</given-names>
</name>
<name>
<surname>Shreve</surname>
<given-names>J.T.</given-names>
</name>
<name>
<surname>Bowen</surname>
<given-names>C.D.</given-names>
</name>
<name>
<surname>Shipley</surname>
<given-names>M.M.</given-names>
</name>
<name>
<surname>Enquist</surname>
<given-names>L.W.</given-names>
</name>
<name>
<surname>Szpara</surname>
<given-names>M.L.</given-names>
</name>
</person-group>
<article-title>Rapid genome assembly and comparison decode intrastrain variation in human alphaherpesviruses</article-title>
<source/>mBio
          <year>2015</year>
<volume>6</volume>
<fpage>e02213-14</fpage>
<pub-id pub-id-type="doi">10.1128/mBio.02213-14</pub-id>
<pub-id pub-id-type="pmid">25827418</pub-id>
</element-citation>
</ref>
<ref id="B45-viruses-11-00966">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pfaff</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Groth</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sauerbrei</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Zell</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Genotyping of herpes simplex virus type 1 by whole-genome sequencing</article-title>
<source/>J. Gen. Virol.
          <year>2016</year>
<volume>97</volume>
<fpage>2732</fpage>
<lpage>2741</lpage>
<pub-id pub-id-type="doi">10.1099/jgv.0.000589</pub-id>
<pub-id pub-id-type="pmid">27558891</pub-id>
</element-citation>
</ref>
<ref id="B46-viruses-11-00966">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sijmons</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Thys</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Mbong Ngwese</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Van Damme</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Dvorak</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Van Loock</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Tachezy</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Busson</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Aerssens</surname>
<given-names>J.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>High-Throughput Analysis of Human Cytomegalovirus Genome Diversity Highlights the Widespread Occurrence of Gene-Disrupting Mutations and Pervasive Recombination</article-title>
<source/>J. Virol.
          <year>2015</year>
<volume>89</volume>
<fpage>7673</fpage>
<lpage>7695</lpage>
<pub-id pub-id-type="doi">10.1128/JVI.00578-15</pub-id>
<pub-id pub-id-type="pmid">25972543</pub-id>
</element-citation>
</ref>
<ref id="B47-viruses-11-00966">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Szpara</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>Gatherer</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Ochoa</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Greenbaum</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Dolan</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bowden</surname>
<given-names>R.J.</given-names>
</name>
<name>
<surname>Enquist</surname>
<given-names>L.W.</given-names>
</name>
<name>
<surname>Legendre</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Davison</surname>
<given-names>A.J.</given-names>
</name>
</person-group>
<article-title>Evolution and diversity in human herpes simplex virus genomes</article-title>
<source/>J. Virol.
          <year>2014</year>
<volume>88</volume>
<fpage>1209</fpage>
<lpage>1227</lpage>
<pub-id pub-id-type="doi">10.1128/JVI.01987-13</pub-id>
<pub-id pub-id-type="pmid">24227835</pub-id>
</element-citation>
</ref>
<ref id="B48-viruses-11-00966">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Szpara</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>Parsons</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Enquist</surname>
<given-names>L.W.</given-names>
</name>
</person-group>
<article-title>Sequence variability in clinical and laboratory isolates of herpes simplex virus 1 reveals new mutations</article-title>
<source/>J. Virol.
          <year>2010</year>
<volume>84</volume>
<fpage>5303</fpage>
<lpage>5313</lpage>
<pub-id pub-id-type="doi">10.1128/JVI.00312-10</pub-id>
<pub-id pub-id-type="pmid">20219902</pub-id>
</element-citation>
</ref>
<ref id="B49-viruses-11-00966">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dix</surname>
<given-names>R.D.</given-names>
</name>
<name>
<surname>McKendall</surname>
<given-names>R.R.</given-names>
</name>
<name>
<surname>Baringer</surname>
<given-names>J.R.</given-names>
</name>
</person-group>
<article-title>Comparative neurovirulence of herpes simplex virus type 1 strains after peripheral or intracerebral inoculation of BALB/c mice</article-title>
<source/>Infect. Immun.
          <year>1983</year>
<volume>40</volume>
<fpage>103</fpage>
<lpage>112</lpage>
<pub-id pub-id-type="pmid">6299955</pub-id>
</element-citation>
</ref>
<ref id="B50-viruses-11-00966">
<label>50.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Davido</surname>
<given-names>D.J.</given-names>
</name>
<name>
<surname>Morrison</surname>
<given-names>L.A.</given-names>
</name>
</person-group>
<article-title>HSV-1 strain McKrae is more neuroinvasive than HSV-1 KOS after corneal or vaginal inoculation in mice</article-title>
<source/>Virus Res.
          <year>2013</year>
<volume>173</volume>
<fpage>436</fpage>
<lpage>440</lpage>
<pub-id pub-id-type="doi">10.1016/j.virusres.2013.01.001</pub-id>
<pub-id pub-id-type="pmid">23339898</pub-id>
</element-citation>
</ref>
<ref id="B51-viruses-11-00966">
<label>51.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kriesel</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>B.B.</given-names>
</name>
<name>
<surname>Matsunami</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>M.K.</given-names>
</name>
<name>
<surname>St. Pierre</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Kurt-Jones</surname>
<given-names>E.A.</given-names>
</name>
<name>
<surname>Finberg</surname>
<given-names>R.W.</given-names>
</name>
<name>
<surname>Leppert</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hobbs</surname>
<given-names>M.R.</given-names>
</name>
</person-group>
<article-title>C21orf91 Genotypes Correlate with Herpes Simplex Labialis (Cold Sore) Frequency: Description of a Cold Sore Susceptibility Gene</article-title>
<source/>J. Infect. Dis.
          <year>2011</year>
<volume>204</volume>
<fpage>1654</fpage>
<lpage>1662</lpage>
<pub-id pub-id-type="doi">10.1093/infdis/jir633</pub-id>
<pub-id pub-id-type="pmid">22039568</pub-id>
</element-citation>
</ref>
<ref id="B52-viruses-11-00966">
<label>52.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thompson</surname>
<given-names>R.L.</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>R.W.</given-names>
</name>
<name>
<surname>Kotb</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sawtell</surname>
<given-names>N.M.</given-names>
</name>
</person-group>
<article-title>A Forward Phenotypically Driven Unbiased Genetic Analysis of Host Genes That Moderate Herpes Simplex Virus Virulence and Stromal Keratitis in Mice</article-title>
<source/>PLoS ONE
          <year>2014</year>
<volume>9</volume>
<elocation-id>e92342</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0092342</pub-id>
<pub-id pub-id-type="pmid">24651695</pub-id>
</element-citation>
</ref>
<ref id="B53-viruses-11-00966">
<label>53.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kriesel</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>Bhatia</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Cold sore susceptibility gene-1 genotypes affect the expression of herpes labialis in unrelated human subjects</article-title>
<source/>Hum. Genome Var.
          <year>2014</year>
<volume>1</volume>
<fpage>14024</fpage>
<pub-id pub-id-type="doi">10.1038/hgv.2014.24</pub-id>
<pub-id pub-id-type="pmid">27081513</pub-id>
</element-citation>
</ref>
<ref id="B54-viruses-11-00966">
<label>54.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pandey</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Renner</surname>
<given-names>D.W.</given-names>
</name>
<name>
<surname>Thompson</surname>
<given-names>R.L.</given-names>
</name>
<name>
<surname>Szpara</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>Sawtell</surname>
<given-names>N.M.</given-names>
</name>
</person-group>
<article-title>Inferred father-to-son transmission of herpes simplex virus results in near-perfect preservation of viral genome identity and in vivo phenotypes</article-title>
<source/>Sci. Rep.
          <year>2017</year>
<volume>7</volume>
<fpage>13666</fpage>
<pub-id pub-id-type="doi">10.1038/s41598-017-13936-6</pub-id>
<pub-id pub-id-type="pmid">29057909</pub-id>
</element-citation>
</ref>
<ref id="B55-viruses-11-00966">
<label>55.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Minaya</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Jensen</surname>
<given-names>T.L.</given-names>
</name>
<name>
<surname>Goll</surname>
<given-names>J.B.</given-names>
</name>
<name>
<surname>Korom</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Datla</surname>
<given-names>S.H.</given-names>
</name>
<name>
<surname>Belshe</surname>
<given-names>R.B.</given-names>
</name>
<name>
<surname>Morrison</surname>
<given-names>L.A.</given-names>
</name>
</person-group>
<article-title>Molecular evolution of herpes simplex virus 2 complete genomes: Comparison between primary and recurrent infections</article-title>
<source/>J. Virol.
          <year>2017</year>
<volume>91</volume>
<fpage>e00942-17</fpage>
<pub-id pub-id-type="doi">10.1128/JVI.00942-17</pub-id>
<pub-id pub-id-type="pmid">28931680</pub-id>
</element-citation>
</ref>
<ref id="B56-viruses-11-00966">
<label>56.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Johnston</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Magaret</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Roychoudhury</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Greninger</surname>
<given-names>A.L.</given-names>
</name>
<name>
<surname>Reeves</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Schiffer</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Jerome</surname>
<given-names>K.R.</given-names>
</name>
<name>
<surname>Sather</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Diem</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Lingappa</surname>
<given-names>J.R.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Dual-strain genital herpes simplex virus type 2 (HSV-2) infection in the US, Peru, and 8 countries in sub-Saharan Africa: A nested cross-sectional viral genotyping study</article-title>
<source/>PLoS Med.
          <year>2017</year>
<volume>14</volume>
<elocation-id>e1002475</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pmed.1002475</pub-id>
<pub-id pub-id-type="pmid">29281620</pub-id>
</element-citation>
</ref>
<ref id="B57-viruses-11-00966">
<label>57.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kleinstein</surname>
<given-names>S.E.</given-names>
</name>
<name>
<surname>Shea</surname>
<given-names>P.R.</given-names>
</name>
<name>
<surname>Allen</surname>
<given-names>A.S.</given-names>
</name>
<name>
<surname>Koelle</surname>
<given-names>D.M.</given-names>
</name>
<name>
<surname>Wald</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Goldstein</surname>
<given-names>D.B.</given-names>
</name>
</person-group>
<article-title>Genome-wide association study (GWAS) of human host factors influencing viral severity of herpes simplex virus type 2 (HSV-2)</article-title>
<source/>Genes Immun.
          <year>2019</year>
<volume>20</volume>
<fpage>112</fpage>
<pub-id pub-id-type="doi">10.1038/s41435-018-0013-4</pub-id>
<pub-id pub-id-type="pmid">29535370</pub-id>
</element-citation>
</ref>
<ref id="B58-viruses-11-00966">
<label>58.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Akhtar</surname>
<given-names>L.N.</given-names>
</name>
<name>
<surname>Bowen</surname>
<given-names>C.D.</given-names>
</name>
<name>
<surname>Renner</surname>
<given-names>D.W.</given-names>
</name>
<name>
<surname>Pandey</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Della Fera</surname>
<given-names>A.N.</given-names>
</name>
<name>
<surname>Kimberlin</surname>
<given-names>D.W.</given-names>
</name>
<name>
<surname>Prichard</surname>
<given-names>M.N.</given-names>
</name>
<name>
<surname>Whitley</surname>
<given-names>R.J.</given-names>
</name>
<name>
<surname>Weitzman</surname>
<given-names>M.D.</given-names>
</name>
<name>
<surname>Szpara</surname>
<given-names>M.L.</given-names>
</name>
</person-group>
<article-title>Genotypic and Phenotypic Diversity of Herpes Simplex Virus 2 within the Infected Neonatal Population</article-title>
<source/>mSphere
          <year>2019</year>
<volume>4</volume>
<fpage>e00590-18</fpage>
<pub-id pub-id-type="doi">10.1128/mSphere.00590-18</pub-id>
<pub-id pub-id-type="pmid">30814317</pub-id>
</element-citation>
</ref>
<ref id="B59-viruses-11-00966">
<label>59.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ramchandani</surname>
<given-names>M.S.</given-names>
</name>
<name>
<surname>Jing</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Russell</surname>
<given-names>R.M.</given-names>
</name>
<name>
<surname>Tran</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Laing</surname>
<given-names>K.J.</given-names>
</name>
<name>
<surname>Magaret</surname>
<given-names>A.S.</given-names>
</name>
<name>
<surname>Selke</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>M.-L.</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>H.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Viral Genetics Modulate Orolabial Herpes Simplex Virus Type 1 Shedding in Humans</article-title>
<source/>J. Infect. Dis.
          <year>2019</year>
<volume>219</volume>
<fpage>1058</fpage>
<lpage>1066</lpage>
<pub-id pub-id-type="doi">10.1093/infdis/jiy631</pub-id>
<pub-id pub-id-type="pmid">30383234</pub-id>
</element-citation>
</ref>
<ref id="B60-viruses-11-00966">
<label>60.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Boldogh</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Albrecht</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Porter</surname>
<given-names>D.D.</given-names>
</name>
</person-group>
<article-title>Persistent Viral Infections</article-title>
<source/>Medical Microbiology
          <person-group person-group-type="editor">
<name>
<surname>Baron</surname>
<given-names>S.</given-names>
</name>
</person-group>
<publisher-name>University of Texas Medical Branch at Galveston</publisher-name>
<publisher-loc>Galveston, TX, USA</publisher-loc>
<year>1996</year>
<isbn>978-0-96-311721-2</isbn>
</element-citation>
</ref>
<ref id="B61-viruses-11-00966">
<label>61.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alawieh</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Elvington</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Tomlinson</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Complement in the Homeostatic and Ischemic Brain</article-title>
<source/>Front. Immunol.
          <year>2015</year>
<volume>6</volume>
<fpage>417</fpage>
<pub-id pub-id-type="doi">10.3389/fimmu.2015.00417</pub-id>
<pub-id pub-id-type="pmid">26322048</pub-id>
</element-citation>
</ref>
<ref id="B62-viruses-11-00966">
<label>62.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boulanger</surname>
<given-names>L.M.</given-names>
</name>
</person-group>
<article-title>Immune Proteins in Brain Development and Synaptic Plasticity</article-title>
<source/>Neuron
          <year>2009</year>
<volume>64</volume>
<fpage>93</fpage>
<lpage>109</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2009.09.001</pub-id>
<pub-id pub-id-type="pmid">19840552</pub-id>
</element-citation>
</ref>
<ref id="B63-viruses-11-00966">
<label>63.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hammad</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Westacott</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zaben</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>The role of the complement system in traumatic brain injury: A review</article-title>
<source/>J. Neuroinflamm.
          <year>2018</year>
<volume>15</volume>
<fpage>24</fpage>
<pub-id pub-id-type="doi">10.1186/s12974-018-1066-z</pub-id>
</element-citation>
</ref>
<ref id="B64-viruses-11-00966">
<label>64.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McAllister</surname>
<given-names>A.K.</given-names>
</name>
</person-group>
<article-title>Major histocompatibility complex I in brain development and schizophrenia</article-title>
<source/>Biol. Psychiatry
          <year>2014</year>
<volume>75</volume>
<fpage>262</fpage>
<lpage>268</lpage>
<pub-id pub-id-type="doi">10.1016/j.biopsych.2013.10.003</pub-id>
<pub-id pub-id-type="pmid">24199663</pub-id>
</element-citation>
</ref>
<ref id="B65-viruses-11-00966">
<label>65.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Needleman</surname>
<given-names>L.A.</given-names>
</name>
<name>
<surname>McAllister</surname>
<given-names>A.K.</given-names>
</name>
</person-group>
<article-title>The Major Histocompatibility Complex and Autism Spectrum Disorder</article-title>
<source/>Dev. Neurobiol.
          <year>2012</year>
<volume>72</volume>
<fpage>1288</fpage>
<lpage>1301</lpage>
<pub-id pub-id-type="doi">10.1002/dneu.22046</pub-id>
<pub-id pub-id-type="pmid">22760919</pub-id>
</element-citation>
</ref>
<ref id="B66-viruses-11-00966">
<label>66.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shatz</surname>
<given-names>C.J.</given-names>
</name>
</person-group>
<article-title>MHC class I: An unexpected role in neuronal plasticity</article-title>
<source/>Neuron
          <year>2009</year>
<volume>64</volume>
<fpage>40</fpage>
<lpage>45</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2009.09.044</pub-id>
<pub-id pub-id-type="pmid">19840547</pub-id>
</element-citation>
</ref>
<ref id="B67-viruses-11-00966">
<label>67.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stephan</surname>
<given-names>A.H.</given-names>
</name>
<name>
<surname>Barres</surname>
<given-names>B.A.</given-names>
</name>
<name>
<surname>Stevens</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>The Complement System: An Unexpected Role in Synaptic Pruning During Development and Disease</article-title>
<source/>Annu. Rev. Neurosci.
          <year>2012</year>
<volume>35</volume>
<fpage>369</fpage>
<lpage>389</lpage>
<pub-id pub-id-type="doi">10.1146/annurev-neuro-061010-113810</pub-id>
<pub-id pub-id-type="pmid">22715882</pub-id>
</element-citation>
</ref>
<ref id="B68-viruses-11-00966">
<label>68.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yirmiya</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Goshen</surname>
<given-names>I.</given-names>
</name>
</person-group>
<article-title>Immune modulation of learning, memory, neural plasticity and neurogenesis</article-title>
<source/>Brain Behav. Immun.
          <year>2011</year>
<volume>25</volume>
<fpage>181</fpage>
<lpage>213</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbi.2010.10.015</pub-id>
<pub-id pub-id-type="pmid">20970492</pub-id>
</element-citation>
</ref>
<ref id="B69-viruses-11-00966">
<label>69.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Knipe</surname>
<given-names>D.M.</given-names>
</name>
<name>
<surname>Cliffe</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Chromatin control of herpes simplex virus lytic and latent infection</article-title>
<source/>Nat. Rev. Microbiol.
          <year>2008</year>
<volume>6</volume>
<fpage>211</fpage>
<lpage>221</lpage>
<pub-id pub-id-type="doi">10.1038/nrmicro1794</pub-id>
<pub-id pub-id-type="pmid">18264117</pub-id>
</element-citation>
</ref>
<ref id="B70-viruses-11-00966">
<label>70.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wilson</surname>
<given-names>A.C.</given-names>
</name>
<name>
<surname>Mohr</surname>
<given-names>I.</given-names>
</name>
</person-group>
<article-title>A cultured affair: HSV latency and reactivation neurons</article-title>
<source/>Trends Microbiol.
          <year>2012</year>
<volume>20</volume>
<fpage>604</fpage>
<lpage>611</lpage>
<pub-id pub-id-type="doi">10.1016/j.tim.2012.08.005</pub-id>
<pub-id pub-id-type="pmid">22963857</pub-id>
</element-citation>
</ref>
<ref id="B71-viruses-11-00966">
<label>71.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mehta</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Maggioncalda</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Bagasra</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Thikkavarapu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Saikumari</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Valyi-Nagy</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Fraser</surname>
<given-names>N.W.</given-names>
</name>
<name>
<surname>Block</surname>
<given-names>T.M.</given-names>
</name>
</person-group>
<article-title>In situ DNA PCR and RNA hybridization detection of herpes simplex virus sequences in trigeminal gangliaof latently infected mice</article-title>
<source/>Virology
          <year>1995</year>
<volume>206</volume>
<fpage>633</fpage>
<lpage>640</lpage>
<pub-id pub-id-type="doi">10.1016/S0042-6822(95)80080-8</pub-id>
<pub-id pub-id-type="pmid">7831818</pub-id>
</element-citation>
</ref>
<ref id="B72-viruses-11-00966">
<label>72.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maggioncalda</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Mehta</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>Y.H.</given-names>
</name>
<name>
<surname>Fraser</surname>
<given-names>N.W.</given-names>
</name>
<name>
<surname>Block</surname>
<given-names>T.M.</given-names>
</name>
</person-group>
<article-title>Correlation between Herpes Simplex Virus Type 1 Rate of Reactivation from Latent Infection and the Number of Infected Neurons in Trigeminal Ganglia</article-title>
<source/>Virology
          <year>1996</year>
<volume>225</volume>
<fpage>72</fpage>
<lpage>81</lpage>
<pub-id pub-id-type="doi">10.1006/viro.1996.0576</pub-id>
<pub-id pub-id-type="pmid">8918535</pub-id>
</element-citation>
</ref>
<ref id="B73-viruses-11-00966">
<label>73.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Lau</surname>
<given-names>T.Y.</given-names>
</name>
<name>
<surname>Morales</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mont</surname>
<given-names>E.K.</given-names>
</name>
<name>
<surname>Straus</surname>
<given-names>S.E.</given-names>
</name>
</person-group>
<article-title>Laser-capture microdissection: Refining estimates of the quantity and distribution of latent herpes simplex virus 1 and varicella-zoster virus DNA in human trigeminal Ganglia at the single-cell level</article-title>
<source/>J. Virol.
          <year>2005</year>
<volume>79</volume>
<fpage>14079</fpage>
<lpage>14087</lpage>
<pub-id pub-id-type="doi">10.1128/JVI.79.22.14079-14087.2005</pub-id>
<pub-id pub-id-type="pmid">16254342</pub-id>
</element-citation>
</ref>
<ref id="B74-viruses-11-00966">
<label>74.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stevens</surname>
<given-names>J.G.</given-names>
</name>
<name>
<surname>Wagner</surname>
<given-names>E.K.</given-names>
</name>
<name>
<surname>Devi-Rao</surname>
<given-names>G.B.</given-names>
</name>
<name>
<surname>Cook</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>Feldman</surname>
<given-names>L.T.</given-names>
</name>
</person-group>
<article-title>RNA complementary to a herpesvirus alpha gene mRNA is prominent in latently infected neurons</article-title>
<source/>Science
          <year>1987</year>
<volume>235</volume>
<fpage>1056</fpage>
<lpage>1059</lpage>
<pub-id pub-id-type="doi">10.1126/science.2434993</pub-id>
<pub-id pub-id-type="pmid">2434993</pub-id>
</element-citation>
</ref>
<ref id="B75-viruses-11-00966">
<label>75.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wagner</surname>
<given-names>E.K.</given-names>
</name>
<name>
<surname>Bloom</surname>
<given-names>D.C.</given-names>
</name>
</person-group>
<article-title>Experimental investigation of herpes simplex virus latency</article-title>
<source/>Clin. Microbiol. Rev.
          <year>1997</year>
<volume>10</volume>
<fpage>419</fpage>
<lpage>443</lpage>
<pub-id pub-id-type="doi">10.1128/CMR.10.3.419</pub-id>
<pub-id pub-id-type="pmid">9227860</pub-id>
</element-citation>
</ref>
<ref id="B76-viruses-11-00966">
<label>76.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zabolotny</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Krummenacher</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Fraser</surname>
<given-names>N.W.</given-names>
</name>
</person-group>
<article-title>The herpes simplex virus type 1 2.0-kilobase latency-associated transcript is a stable intron which branches at a guanosine</article-title>
<source/>J. Virol.
          <year>1997</year>
<volume>71</volume>
<fpage>4199</fpage>
<lpage>4208</lpage>
<pub-id pub-id-type="pmid">9151806</pub-id>
</element-citation>
</ref>
<ref id="B77-viruses-11-00966">
<label>77.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>S.H.</given-names>
</name>
<name>
<surname>Kramer</surname>
<given-names>M.F.</given-names>
</name>
<name>
<surname>Schaffer</surname>
<given-names>P.A.</given-names>
</name>
<name>
<surname>Coen</surname>
<given-names>D.M.</given-names>
</name>
</person-group>
<article-title>A viral function represses accumulation of transcripts from productive-cycle genes in mouse ganglia latently infected with herpes simplex virus</article-title>
<source/>J. Virol.
          <year>1997</year>
<volume>71</volume>
<fpage>5878</fpage>
<lpage>5884</lpage>
<pub-id pub-id-type="pmid">9223477</pub-id>
</element-citation>
</ref>
<ref id="B78-viruses-11-00966">
<label>78.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mador</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Goldenberg</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Cohen</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Panet</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Steiner</surname>
<given-names>I.</given-names>
</name>
</person-group>
<article-title>Herpes Simplex Virus Type 1 Latency-Associated Transcripts Suppress Viral Replication and Reduce Immediate-Early Gene mRNA Levels in a Neuronal Cell Line</article-title>
<source/>J. Virol.
          <year>1998</year>
<volume>72</volume>
<fpage>5067</fpage>
<lpage>5075</lpage>
<pub-id pub-id-type="pmid">9573277</pub-id>
</element-citation>
</ref>
<ref id="B79-viruses-11-00966">
<label>79.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nicoll</surname>
<given-names>M.P.</given-names>
</name>
<name>
<surname>Hann</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Shivkumar</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Harman</surname>
<given-names>L.E.R.</given-names>
</name>
<name>
<surname>Connor</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Coleman</surname>
<given-names>H.M.</given-names>
</name>
<name>
<surname>Proença</surname>
<given-names>J.T.</given-names>
</name>
<name>
<surname>Efstathiou</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>The HSV-1 Latency-Associated Transcript Functions to Repress Latent Phase Lytic Gene Expression and Suppress Virus Reactivation from Latently Infected Neurons</article-title>
<source/>PLoS Pathog.
          <year>2016</year>
<volume>12</volume>
<elocation-id>e1005539</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.ppat.1005539</pub-id>
<pub-id pub-id-type="pmid">27055281</pub-id>
</element-citation>
</ref>
<ref id="B80-viruses-11-00966">
<label>80.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thompson</surname>
<given-names>R.L.</given-names>
</name>
<name>
<surname>Sawtell</surname>
<given-names>N.M.</given-names>
</name>
</person-group>
<article-title>The herpes simplex virus type 1 latency-associated transcript gene regulates the establishment of latency</article-title>
<source/>J. Virol.
          <year>1997</year>
<volume>71</volume>
<fpage>5432</fpage>
<lpage>5440</lpage>
<pub-id pub-id-type="pmid">9188615</pub-id>
</element-citation>
</ref>
<ref id="B81-viruses-11-00966">
<label>81.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thompson</surname>
<given-names>R.L.</given-names>
</name>
<name>
<surname>Sawtell</surname>
<given-names>N.M.</given-names>
</name>
</person-group>
<article-title>The herpes simplex virus type 1 latency associated transcript locus is required for the maintenance of reactivation competent latent infections</article-title>
<source/>J. Neurovirol.
          <year>2011</year>
<volume>17</volume>
<fpage>552</fpage>
<lpage>558</lpage>
<pub-id pub-id-type="doi">10.1007/s13365-011-0071-0</pub-id>
<pub-id pub-id-type="pmid">22207584</pub-id>
</element-citation>
</ref>
<ref id="B82-viruses-11-00966">
<label>82.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thompson</surname>
<given-names>R.L.</given-names>
</name>
<name>
<surname>Sawtell</surname>
<given-names>N.M.</given-names>
</name>
</person-group>
<article-title>Herpes simplex virus type 1 latency-associated transcript gene promotes neuronal survival</article-title>
<source/>J. Virol.
          <year>2001</year>
<volume>75</volume>
<fpage>6660</fpage>
<lpage>6675</lpage>
<pub-id pub-id-type="doi">10.1128/JVI.75.14.6660-6675.2001</pub-id>
<pub-id pub-id-type="pmid">11413333</pub-id>
</element-citation>
</ref>
<ref id="B83-viruses-11-00966">
<label>83.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perng</surname>
<given-names>G.C.</given-names>
</name>
<name>
<surname>Dunkel</surname>
<given-names>E.C.</given-names>
</name>
<name>
<surname>Geary</surname>
<given-names>P.A.</given-names>
</name>
<name>
<surname>Slanina</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Ghiasi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Kaiwar</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Nesburn</surname>
<given-names>A.B.</given-names>
</name>
<name>
<surname>Wechsler</surname>
<given-names>S.L.</given-names>
</name>
</person-group>
<article-title>The latency-associated transcript gene of herpes simplex virus type 1 (HSV-1) is required for efficient in vivo spontaneous reactivation of HSV-1 from latency</article-title>
<source/>J. Virol.
          <year>1994</year>
<volume>68</volume>
<fpage>8045</fpage>
<lpage>8055</lpage>
<pub-id pub-id-type="pmid">7966594</pub-id>
</element-citation>
</ref>
<ref id="B84-viruses-11-00966">
<label>84.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shen</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>e Silva</surname>
<given-names>M.S.</given-names>
</name>
<name>
<surname>Jaber</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Vitvitskaia</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Henderson</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Two Small RNAs Encoded within the First 1.5 Kilobases of the Herpes Simplex Virus Type 1 Latency-Associated Transcript Can Inhibit Productive Infection and Cooperate to Inhibit Apoptosis</article-title>
<source/>J. Virol.
          <year>2009</year>
<volume>83</volume>
<fpage>9131</fpage>
<lpage>9139</lpage>
<pub-id pub-id-type="doi">10.1128/JVI.00871-09</pub-id>
<pub-id pub-id-type="pmid">19587058</pub-id>
</element-citation>
</ref>
<ref id="B85-viruses-11-00966">
<label>85.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Umbach</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Kramer</surname>
<given-names>M.F.</given-names>
</name>
<name>
<surname>Jurak</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Karnowski</surname>
<given-names>H.W.</given-names>
</name>
<name>
<surname>Coen</surname>
<given-names>D.M.</given-names>
</name>
<name>
<surname>Cullen</surname>
<given-names>B.R.</given-names>
</name>
</person-group>
<article-title>MicroRNAs expressed by herpes simplex virus 1 during latent infection regulate viral mRNAs</article-title>
<source/>Nature
          <year>2008</year>
<volume>454</volume>
<fpage>1</fpage>
<lpage>6</lpage>
<pub-id pub-id-type="doi">10.1038/nature07103</pub-id>
<pub-id pub-id-type="pmid">18596690</pub-id>
</element-citation>
</ref>
<ref id="B86-viruses-11-00966">
<label>86.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Green</surname>
<given-names>M.T.</given-names>
</name>
<name>
<surname>Courtney</surname>
<given-names>R.J.</given-names>
</name>
<name>
<surname>Dunkel</surname>
<given-names>E.C.</given-names>
</name>
</person-group>
<article-title>Detection of an immediate early herpes simplex virus type 1 polypeptide in trigeminal ganglia from latently infected animals</article-title>
<source/>Infect. Immun.
          <year>1981</year>
<volume>34</volume>
<fpage>987</fpage>
<lpage>992</lpage>
<pub-id pub-id-type="pmid">7037648</pub-id>
</element-citation>
</ref>
<ref id="B87-viruses-11-00966">
<label>87.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kramer</surname>
<given-names>M.F.</given-names>
</name>
<name>
<surname>Coen</surname>
<given-names>D.M.</given-names>
</name>
</person-group>
<article-title>Quantification of transcripts from the ICP4 and thymidine kinase genes in mouse ganglia latently infected with herpes simplex virus</article-title>
<source/>J. Virol.
          <year>1995</year>
<volume>69</volume>
<fpage>1389</fpage>
<lpage>1399</lpage>
<pub-id pub-id-type="pmid">7853471</pub-id>
</element-citation>
</ref>
<ref id="B88-viruses-11-00966">
<label>88.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Feldman</surname>
<given-names>L.T.</given-names>
</name>
<name>
<surname>Ellison</surname>
<given-names>A.R.</given-names>
</name>
<name>
<surname>Voytek</surname>
<given-names>C.C.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Krause</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Margolis</surname>
<given-names>T.P.</given-names>
</name>
</person-group>
<article-title>Spontaneous molecular reactivation of herpes simplex virus type 1 latency in mice</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2002</year>
<volume>99</volume>
<fpage>978</fpage>
<lpage>983</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.022301899</pub-id>
<pub-id pub-id-type="pmid">11773630</pub-id>
</element-citation>
</ref>
<ref id="B89-viruses-11-00966">
<label>89.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khanna</surname>
<given-names>K.M.</given-names>
</name>
<name>
<surname>Bonneau</surname>
<given-names>R.H.</given-names>
</name>
<name>
<surname>Kinchington</surname>
<given-names>P.R.</given-names>
</name>
<name>
<surname>Hendricks</surname>
<given-names>R.L.</given-names>
</name>
</person-group>
<article-title>Herpes Simplex Virus-Specific Memory CD8^ T Cells Are Selectively Activated and Retained in Latently Infected Sensory Ganglia</article-title>
<source/>Immunity
          <year>2003</year>
<volume>18</volume>
<fpage>593</fpage>
<lpage>603</lpage>
<pub-id pub-id-type="doi">10.1016/S1074-7613(03)00112-2</pub-id>
<pub-id pub-id-type="pmid">12753737</pub-id>
</element-citation>
</ref>
<ref id="B90-viruses-11-00966">
<label>90.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cliffe</surname>
<given-names>A.R.</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>A.C.</given-names>
</name>
</person-group>
<article-title>Restarting Lytic Gene Transcription at the Onset of Herpes Simplex Virus Reactivation</article-title>
<source/>J. Virol.
          <year>2017</year>
<volume>91</volume>
<fpage>e01419-16</fpage>
<pub-id pub-id-type="doi">10.1128/JVI.01419-16</pub-id>
</element-citation>
</ref>
<ref id="B91-viruses-11-00966">
<label>91.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Linderman</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Kobayashi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Rayannavar</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Fak</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Darnell</surname>
<given-names>R.B.</given-names>
</name>
<name>
<surname>Chao</surname>
<given-names>M.V.</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>A.C.</given-names>
</name>
<name>
<surname>Mohr</surname>
<given-names>I.</given-names>
</name>
</person-group>
<article-title>Immune Escape via a Transient Gene Expression Program Enables Productive Replication of a Latent Pathogen</article-title>
<source/>Cell Rep.
          <year>2017</year>
<volume>18</volume>
<fpage>1312</fpage>
<lpage>1323</lpage>
<pub-id pub-id-type="doi">10.1016/j.celrep.2017.01.017</pub-id>
<pub-id pub-id-type="pmid">28147283</pub-id>
</element-citation>
</ref>
<ref id="B92-viruses-11-00966">
<label>92.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kang</surname>
<given-names>M.-S.</given-names>
</name>
<name>
<surname>Kieff</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Epstein–Barr virus latent genes</article-title>
<source/>Exp. Mol. Med.
          <year>2015</year>
<volume>47</volume>
<fpage>e131</fpage>
<pub-id pub-id-type="doi">10.1038/emm.2014.84</pub-id>
<pub-id pub-id-type="pmid">25613728</pub-id>
</element-citation>
</ref>
<ref id="B93-viruses-11-00966">
<label>93.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Longnecker</surname>
<given-names>R.M.</given-names>
</name>
<name>
<surname>Kieff</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Cohen</surname>
<given-names>J.I.</given-names>
</name>
</person-group>
<article-title>Epstein-barr virus</article-title>
<source/>Fields Virology
          <edition>6th ed.</edition>
<person-group person-group-type="editor">
<name>
<surname>Knipe</surname>
<given-names>D.M.</given-names>
</name>
<name>
<surname>Howley</surname>
<given-names>P.</given-names>
</name>
</person-group>
<publisher-name>Wolters Kluwer</publisher-name>
<publisher-loc>Alphen aan den Rijn, The Netherlands</publisher-loc>
<year>2013</year>
</element-citation>
</ref>
<ref id="B94-viruses-11-00966">
<label>94.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khanna</surname>
<given-names>K.M.</given-names>
</name>
<name>
<surname>Lepisto</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>Hendricks</surname>
<given-names>R.L.</given-names>
</name>
</person-group>
<article-title>Immunity to latent viral infection: Many skirmishes but few fatalities</article-title>
<source/>Trends Immunol.
          <year>2004</year>
<volume>25</volume>
<fpage>230</fpage>
<lpage>234</lpage>
<pub-id pub-id-type="doi">10.1016/j.it.2004.02.010</pub-id>
<pub-id pub-id-type="pmid">15099562</pub-id>
</element-citation>
</ref>
<ref id="B95-viruses-11-00966">
<label>95.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Medzhitov</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Origin and physiological roles of inflammation</article-title>
<source/>Nat. Lond.
          <year>2008</year>
<volume>454</volume>
<fpage>428</fpage>
<lpage>435</lpage>
<pub-id pub-id-type="doi">10.1038/nature07201</pub-id>
<pub-id pub-id-type="pmid">18650913</pub-id>
</element-citation>
</ref>
<ref id="B96-viruses-11-00966">
<label>96.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Warren</surname>
<given-names>K.G.</given-names>
</name>
<name>
<surname>Wroblewska</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Okabe</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Gilden</surname>
<given-names>D.H.</given-names>
</name>
<name>
<surname>Koprowski</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Rorke</surname>
<given-names>L.B.</given-names>
</name>
<name>
<surname>Subak-Sharpe</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Yonezawa</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Virology and histopathology of the trigeminal ganglia of Americans and Japanese</article-title>
<source/>Can. J. Neurol. Sci.
          <year>1978</year>
<volume>5</volume>
<fpage>425</fpage>
<lpage>430</lpage>
<pub-id pub-id-type="doi">10.1017/S0317167100024215</pub-id>
<pub-id pub-id-type="pmid">217518</pub-id>
</element-citation>
</ref>
<ref id="B97-viruses-11-00966">
<label>97.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Joly</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Mucke</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Oldstone</surname>
<given-names>M.B.</given-names>
</name>
</person-group>
<article-title>Viral persistence in neurons explained by lack of major histocompatibility class I expression</article-title>
<source/>Science
          <year>1991</year>
<volume>253</volume>
<fpage>1283</fpage>
<lpage>1285</lpage>
<pub-id pub-id-type="doi">10.1126/science.1891717</pub-id>
<pub-id pub-id-type="pmid">1891717</pub-id>
</element-citation>
</ref>
<ref id="B98-viruses-11-00966">
<label>98.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Neuwelt</surname>
<given-names>E.A.</given-names>
</name>
<name>
<surname>Clark</surname>
<given-names>W.K.</given-names>
</name>
</person-group>
<article-title>Unique aspects of central nervous system immunology</article-title>
<source/>Neurosurgery
          <year>1978</year>
<volume>3</volume>
<fpage>419</fpage>
<lpage>430</lpage>
<pub-id pub-id-type="pmid">368670</pub-id>
</element-citation>
</ref>
<ref id="B99-viruses-11-00966">
<label>99.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shirai</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>On the transplantation of the rat sarcoma in adult heterogeneous animals</article-title>
<source/>Jpn. Med. World
          <year>1921</year>
<volume>1</volume>
<fpage>14</fpage>
<lpage>15</lpage>
</element-citation>
</ref>
<ref id="B100-viruses-11-00966">
<label>100.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Murphy</surname>
<given-names>J.B.</given-names>
</name>
<name>
<surname>Sturm</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Conditions determining the transplantability of tissues in the brain</article-title>
<source/>J. Exp. Med.
          <year>1923</year>
<volume>38</volume>
<fpage>183</fpage>
<lpage>197</lpage>
<pub-id pub-id-type="doi">10.1084/jem.38.2.183</pub-id>
<pub-id pub-id-type="pmid">19868782</pub-id>
</element-citation>
</ref>
<ref id="B101-viruses-11-00966">
<label>101.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cebrián</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Loike</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>Sulzer</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Neuronal MHC-I expression and its implications in synaptic function, axonal regeneration and Parkinson’s and other brain diseases</article-title>
<source/>Front. Neuroanat.
          <year>2014</year>
<volume>8</volume>
<fpage>114</fpage>
<pub-id pub-id-type="doi">10.3389/fnana.2014.00114</pub-id>
<pub-id pub-id-type="pmid">25352786</pub-id>
</element-citation>
</ref>
<ref id="B102-viruses-11-00966">
<label>102.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mangold</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Masser</surname>
<given-names>D.R.</given-names>
</name>
<name>
<surname>Stanford</surname>
<given-names>D.R.</given-names>
</name>
<name>
<surname>Bixler</surname>
<given-names>G.V.</given-names>
</name>
<name>
<surname>Pisupati</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Giles</surname>
<given-names>C.B.</given-names>
</name>
<name>
<surname>Wren</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>Ford</surname>
<given-names>M.M.</given-names>
</name>
<name>
<surname>Sonntag</surname>
<given-names>W.E.</given-names>
</name>
<name>
<surname>Freeman</surname>
<given-names>W.M.</given-names>
</name>
</person-group>
<article-title>CNS-wide Sexually Dimorphic Induction of the Major Histocompatibility Complex 1 Pathway with Aging</article-title>
<source/>J. Gerontol. A Biol. Sci. Med. Sci.
          <year>2017</year>
<volume>72</volume>
<fpage>16</fpage>
<lpage>29</lpage>
<pub-id pub-id-type="doi">10.1093/gerona/glv232</pub-id>
<pub-id pub-id-type="pmid">26786204</pub-id>
</element-citation>
</ref>
<ref id="B103-viruses-11-00966">
<label>103.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mangold</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Wronowski</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Masser</surname>
<given-names>D.R.</given-names>
</name>
<name>
<surname>Hadad</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Bixler</surname>
<given-names>G.V.</given-names>
</name>
<name>
<surname>Brucklacher</surname>
<given-names>R.M.</given-names>
</name>
<name>
<surname>Ford</surname>
<given-names>M.M.</given-names>
</name>
<name>
<surname>Sonntag</surname>
<given-names>W.E.</given-names>
</name>
<name>
<surname>Freeman</surname>
<given-names>W.M.</given-names>
</name>
</person-group>
<article-title>Sexually divergent induction of microglial-associated neuroinflammation with hippocampal aging</article-title>
<source/>J. Neuroinflamm.
          <year>2017</year>
<volume>14</volume>
<fpage>141</fpage>
<pub-id pub-id-type="doi">10.1186/s12974-017-0920-8</pub-id>
</element-citation>
</ref>
<ref id="B104-viruses-11-00966">
<label>104.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Starkey</surname>
<given-names>H.D.V.</given-names>
</name>
<name>
<surname>Van Kirk</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Bixler</surname>
<given-names>G.V.</given-names>
</name>
<name>
<surname>Imperio</surname>
<given-names>C.G.</given-names>
</name>
<name>
<surname>Kale</surname>
<given-names>V.P.</given-names>
</name>
<name>
<surname>Serfass</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Farley</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Warrington</surname>
<given-names>J.P.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>S.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Neuroglial Expression of the MHCI Pathway and PirB Receptor Is Upregulated in the Hippocampus with Advanced Aging</article-title>
<source/>J. Mol. Neurosci.
          <year>2012</year>
<volume>48</volume>
<fpage>111</fpage>
<lpage>126</lpage>
<pub-id pub-id-type="doi">10.1007/s12031-012-9783-8</pub-id>
<pub-id pub-id-type="pmid">22562814</pub-id>
</element-citation>
</ref>
<ref id="B105-viruses-11-00966">
<label>105.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Long</surname>
<given-names>L.-H.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>R.-L.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>Z.-L.</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J.-G.</given-names>
</name>
</person-group>
<article-title>Age-related synaptic changes in the CA1 stratum radiatum and spatial learning impairment in rats</article-title>
<source/>Clin. Exp. Pharm. Physiol.
          <year>2009</year>
<volume>36</volume>
<fpage>675</fpage>
<lpage>681</lpage>
<pub-id pub-id-type="doi">10.1111/j.1440-1681.2008.05132.x</pub-id>
<pub-id pub-id-type="pmid">19594553</pub-id>
</element-citation>
</ref>
<ref id="B106-viruses-11-00966">
<label>106.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shi</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Linville</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Tucker</surname>
<given-names>E.W.</given-names>
</name>
<name>
<surname>Sonntag</surname>
<given-names>W.E.</given-names>
</name>
<name>
<surname>Brunso-Bechtold</surname>
<given-names>J.K.</given-names>
</name>
</person-group>
<article-title>Differential effects of aging and insulin-like growth factor-1 on synapses in CA1 of rat hippocampus</article-title>
<source/>Cereb. Cortex
          <year>2005</year>
<volume>15</volume>
<fpage>571</fpage>
<lpage>577</lpage>
<pub-id pub-id-type="doi">10.1093/cercor/bhh158</pub-id>
<pub-id pub-id-type="pmid">15319312</pub-id>
</element-citation>
</ref>
<ref id="B107-viruses-11-00966">
<label>107.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>A.K.Y.</given-names>
</name>
<name>
<surname>Ip</surname>
<given-names>N.Y.</given-names>
</name>
</person-group>
<article-title>Synaptic dysfunction in Alzheimer’s disease: Mechanisms and therapeutic strategies</article-title>
<source/>Pharmacol. Ther.
          <year>2019</year>
<volume>195</volume>
<fpage>186</fpage>
<lpage>198</lpage>
<pub-id pub-id-type="doi">10.1016/j.pharmthera.2018.11.006</pub-id>
<pub-id pub-id-type="pmid">30439458</pub-id>
</element-citation>
</ref>
<ref id="B108-viruses-11-00966">
<label>108.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lassmann</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Weiler</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Fischer</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Bancher</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Jellinger</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Floor</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Danielczyk</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Seitelberger</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Winkler</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Synaptic pathology in Alzheimer’s disease: Immunological data for markers of synaptic and large dense-core vesicles</article-title>
<source/>Neuroscience
          <year>1992</year>
<volume>46</volume>
<fpage>1</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1016/0306-4522(92)90003-K</pub-id>
<pub-id pub-id-type="pmid">1594095</pub-id>
</element-citation>
</ref>
<ref id="B109-viruses-11-00966">
<label>109.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Masliah</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Mallory</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Alford</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>DeTeresa</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Hansen</surname>
<given-names>L.A.</given-names>
</name>
<name>
<surname>McKeel</surname>
<given-names>D.W.</given-names>
</name>
<name>
<surname>Morris</surname>
<given-names>J.C.</given-names>
</name>
</person-group>
<article-title>Altered expression of synaptic proteins occurs early during progression of Alzheimer’s disease</article-title>
<source/>Neurology
          <year>2001</year>
<volume>56</volume>
<fpage>127</fpage>
<lpage>129</lpage>
<pub-id pub-id-type="doi">10.1212/WNL.56.1.127</pub-id>
<pub-id pub-id-type="pmid">11148253</pub-id>
</element-citation>
</ref>
<ref id="B110-viruses-11-00966">
<label>110.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rajmohan</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Reddy</surname>
<given-names>P.H.</given-names>
</name>
</person-group>
<article-title>Amyloid-Beta and Phosphorylated Tau Accumulations Cause Abnormalities at Synapses of Alzheimer’s disease Neurons</article-title>
<source/>J. Alzheimers Dis.
          <year>2017</year>
<volume>57</volume>
<fpage>975</fpage>
<lpage>999</lpage>
<pub-id pub-id-type="doi">10.3233/JAD-160612</pub-id>
<pub-id pub-id-type="pmid">27567878</pub-id>
</element-citation>
</ref>
<ref id="B111-viruses-11-00966">
<label>111.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reddy</surname>
<given-names>P.H.</given-names>
</name>
<name>
<surname>Mani</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>B.S.</given-names>
</name>
<name>
<surname>Jacques</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Murdoch</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Whetsell</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Kaye</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Manczak</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Differential loss of synaptic proteins in Alzheimer’s disease: Implications for synaptic dysfunction</article-title>
<source/>J. Alzheimers Dis.
          <year>2005</year>
<volume>7</volume>
<fpage>103</fpage>
<lpage>117</lpage>
<comment>discussion 173–180</comment>
<pub-id pub-id-type="doi">10.3233/JAD-2005-7203</pub-id>
<pub-id pub-id-type="pmid">15851848</pub-id>
</element-citation>
</ref>
<ref id="B112-viruses-11-00966">
<label>112.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Selkoe</surname>
<given-names>D.J.</given-names>
</name>
</person-group>
<article-title>Alzheimer’s disease is a synaptic failure</article-title>
<source/>Science
          <year>2002</year>
<volume>298</volume>
<fpage>789</fpage>
<lpage>791</lpage>
<pub-id pub-id-type="doi">10.1126/science.1074069</pub-id>
<pub-id pub-id-type="pmid">12399581</pub-id>
</element-citation>
</ref>
<ref id="B113-viruses-11-00966">
<label>113.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Selkoe</surname>
<given-names>D.J.</given-names>
</name>
</person-group>
<article-title>Alzheimer Disease: Mechanistic Understanding Predicts Novel Therapies</article-title>
<source/>Ann. Intern. Med. Phila.
          <year>2004</year>
<volume>140</volume>
<fpage>627</fpage>
<lpage>638</lpage>
<pub-id pub-id-type="doi">10.7326/0003-4819-140-8-200404200-00047</pub-id>
</element-citation>
</ref>
<ref id="B114-viruses-11-00966">
<label>114.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cárdenas-Aguayo</surname>
<given-names>M.D.C.</given-names>
</name>
<name>
<surname>Silva-Lucero</surname>
<given-names>M.D.C.</given-names>
</name>
<name>
<surname>Cortes-Ortiz</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Jiménez-Ramos</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Gómez-Virgilio</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Ramírez-Rodríguez</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Vera-Arroyo</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Fiorentino-Pérez</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>García</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Luna-Muñoz</surname>
<given-names>J.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Physiological Role of Amyloid Beta in Neural Cells: The Cellular Trophic Activity</article-title>
<source/>Neurochemistry
          <year>2014</year>
<fpage>257</fpage>
<lpage>281</lpage>
<pub-id pub-id-type="doi">10.5772/57398</pub-id>
</element-citation>
</ref>
<ref id="B115-viruses-11-00966">
<label>115.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bouras</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Hof</surname>
<given-names>P.R.</given-names>
</name>
<name>
<surname>Giannakopoulos</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Michel</surname>
<given-names>J.P.</given-names>
</name>
<name>
<surname>Morrison</surname>
<given-names>J.H.</given-names>
</name>
</person-group>
<article-title>Regional distribution of neurofibrillary tangles and senile plaques in the cerebral cortex of elderly patients: A quantitative evaluation of a one-year autopsy population from a geriatric hospital</article-title>
<source/>Cereb. Cortex
          <year>1994</year>
<volume>4</volume>
<fpage>138</fpage>
<lpage>150</lpage>
<pub-id pub-id-type="doi">10.1093/cercor/4.2.138</pub-id>
<pub-id pub-id-type="pmid">8038565</pub-id>
</element-citation>
</ref>
<ref id="B116-viruses-11-00966">
<label>116.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cummings</surname>
<given-names>B.J.</given-names>
</name>
<name>
<surname>Pike</surname>
<given-names>C.J.</given-names>
</name>
<name>
<surname>Shankle</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Cotman</surname>
<given-names>C.W.</given-names>
</name>
</person-group>
<article-title>Beta-amyloid deposition and other measures of neuropathology predict cognitive status in Alzheimer’s disease</article-title>
<source/>Neurobiol. Aging
          <year>1996</year>
<volume>17</volume>
<fpage>921</fpage>
<lpage>933</lpage>
<pub-id pub-id-type="doi">10.1016/S0197-4580(96)00170-4</pub-id>
<pub-id pub-id-type="pmid">9363804</pub-id>
</element-citation>
</ref>
<ref id="B117-viruses-11-00966">
<label>117.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nelson</surname>
<given-names>P.T.</given-names>
</name>
<name>
<surname>Alafuzoff</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Bigio</surname>
<given-names>E.H.</given-names>
</name>
<name>
<surname>Bouras</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Braak</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Cairns</surname>
<given-names>N.J.</given-names>
</name>
<name>
<surname>Castellani</surname>
<given-names>R.J.</given-names>
</name>
<name>
<surname>Crain</surname>
<given-names>B.J.</given-names>
</name>
<name>
<surname>Davies</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Del Tredici</surname>
<given-names>K.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Correlation of Alzheimer Disease Neuropathologic Changes with Cognitive Status: A Review of the Literature</article-title>
<source/>J. Neuropathol. Exp. Neurol
          <year>2012</year>
<volume>71</volume>
<fpage>362</fpage>
<lpage>381</lpage>
<pub-id pub-id-type="doi">10.1097/NEN.0b013e31825018f7</pub-id>
<pub-id pub-id-type="pmid">22487856</pub-id>
</element-citation>
</ref>
<ref id="B118-viruses-11-00966">
<label>118.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Näslund</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Haroutunian</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Mohs</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>K.L.</given-names>
</name>
<name>
<surname>Davies</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Greengard</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Buxbaum</surname>
<given-names>J.D.</given-names>
</name>
</person-group>
<article-title>Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline</article-title>
<source/>JAMA
          <year>2000</year>
<volume>283</volume>
<fpage>1571</fpage>
<lpage>1577</lpage>
<pub-id pub-id-type="doi">10.1001/jama.283.12.1571</pub-id>
<pub-id pub-id-type="pmid">10735393</pub-id>
</element-citation>
</ref>
<ref id="B119-viruses-11-00966">
<label>119.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blessed</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Tomlinson</surname>
<given-names>B.E.</given-names>
</name>
<name>
<surname>Roth</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>The Association Between Quantitative Measures of Dementia and of Senile Change in the Cerebral Grey Matter of Elderly Subjects</article-title>
<source/>Br. J. Psychiatry
          <year>1968</year>
<volume>114</volume>
<fpage>797</fpage>
<lpage>811</lpage>
<pub-id pub-id-type="doi">10.1192/bjp.114.512.797</pub-id>
<pub-id pub-id-type="pmid">5662937</pub-id>
</element-citation>
</ref>
<ref id="B120-viruses-11-00966">
<label>120.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moya</surname>
<given-names>K.L.</given-names>
</name>
<name>
<surname>Benowitz</surname>
<given-names>L.I.</given-names>
</name>
<name>
<surname>Schneider</surname>
<given-names>G.E.</given-names>
</name>
<name>
<surname>Allinquant</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>The amyloid precursor protein is developmentally regulated and correlated with synaptogenesis</article-title>
<source/>Dev. Biol.
          <year>1994</year>
<volume>161</volume>
<fpage>597</fpage>
<lpage>603</lpage>
<pub-id pub-id-type="doi">10.1006/dbio.1994.1055</pub-id>
<pub-id pub-id-type="pmid">8314003</pub-id>
</element-citation>
</ref>
<ref id="B121-viruses-11-00966">
<label>121.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mileusnic</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Lancashire</surname>
<given-names>C.L.</given-names>
</name>
<name>
<surname>Johnston</surname>
<given-names>A.N.</given-names>
</name>
<name>
<surname>Rose</surname>
<given-names>S.P.</given-names>
</name>
</person-group>
<article-title>APP is required during an early phase of memory formation</article-title>
<source/>Eur. J. Neurosci.
          <year>2000</year>
<volume>12</volume>
<fpage>4487</fpage>
<lpage>4495</lpage>
<pub-id pub-id-type="pmid">11122359</pub-id>
</element-citation>
</ref>
<ref id="B122-viruses-11-00966">
<label>122.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kolarova</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>García-Sierra</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Bartos</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ricny</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ripova</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Structure and Pathology of Tau Protein in Alzheimer Disease</article-title>
<source/>Int. J. Alzheimer’s Dis.
          <year>2012</year>
<volume>2012</volume>
<fpage>731526</fpage>
<pub-id pub-id-type="doi">10.1155/2012/731526</pub-id>
<pub-id pub-id-type="pmid">22690349</pub-id>
</element-citation>
</ref>
<ref id="B123-viruses-11-00966">
<label>123.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Braak</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Braak</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Mandelkow</surname>
<given-names>E.M.</given-names>
</name>
</person-group>
<article-title>A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads</article-title>
<source/>Acta Neuropathol.
          <year>1994</year>
<volume>87</volume>
<fpage>554</fpage>
<lpage>567</lpage>
<pub-id pub-id-type="doi">10.1007/BF00293315</pub-id>
<pub-id pub-id-type="pmid">7522386</pub-id>
</element-citation>
</ref>
<ref id="B124-viruses-11-00966">
<label>124.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mandelkow</surname>
<given-names>E.-M.</given-names>
</name>
<name>
<surname>Stamer</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Vogel</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Thies</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Mandelkow</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Clogging of axons by tau, inhibition of axonal traffic and starvation of synapses</article-title>
<source/>Neurobiol. Aging
          <year>2003</year>
<volume>24</volume>
<fpage>1079</fpage>
<lpage>1085</lpage>
<pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2003.04.007</pub-id>
<pub-id pub-id-type="pmid">14643379</pub-id>
</element-citation>
</ref>
<ref id="B125-viruses-11-00966">
<label>125.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Buée</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Bussière</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Buée-Scherrer</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Delacourte</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hof</surname>
<given-names>P.R.</given-names>
</name>
</person-group>
<article-title>Tau protein isoforms, phosphorylation and role in neurodegenerative disorders11These authors contributed equally to this work</article-title>
<source/>Brain Res. Rev.
          <year>2000</year>
<volume>33</volume>
<fpage>95</fpage>
<lpage>130</lpage>
<pub-id pub-id-type="doi">10.1016/S0165-0173(00)00019-9</pub-id>
<pub-id pub-id-type="pmid">10967355</pub-id>
</element-citation>
</ref>
<ref id="B126-viruses-11-00966">
<label>126.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lovestone</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Reynolds</surname>
<given-names>C.H.</given-names>
</name>
</person-group>
<article-title>The phosphorylation of tau: A critical stage in neurodevelopment and neurodegenerative processes</article-title>
<source/>Neuroscience
          <year>1997</year>
<volume>78</volume>
<fpage>309</fpage>
<lpage>324</lpage>
<pub-id pub-id-type="pmid">9145789</pub-id>
</element-citation>
</ref>
<ref id="B127-viruses-11-00966">
<label>127.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vermersch</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>David</surname>
<given-names>J.P.</given-names>
</name>
<name>
<surname>Frigard</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Fallet-Bianco</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Wattez</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Petit</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Delacourte</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Cortical mapping of Alzheimer pathology in brains of aged non-demented subjects</article-title>
<source/>Prog. Neuropsychopharmacol. Biol. Psychiatry
          <year>1995</year>
<volume>19</volume>
<fpage>1035</fpage>
<lpage>1047</lpage>
<pub-id pub-id-type="doi">10.1016/0278-5846(95)00195-6</pub-id>
<pub-id pub-id-type="pmid">8584681</pub-id>
</element-citation>
</ref>
<ref id="B128-viruses-11-00966">
<label>128.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vermersch</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Frigard</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>David</surname>
<given-names>J.P.</given-names>
</name>
<name>
<surname>Fallet-Bianco</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Delacourte</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Presence of abnormally phosphorylated Tau proteins in the entorhinal cortex of aged non-demented subjects</article-title>
<source/>Neurosci. Lett.
          <year>1992</year>
<volume>144</volume>
<fpage>143</fpage>
<lpage>146</lpage>
<pub-id pub-id-type="doi">10.1016/0304-3940(92)90736-Q</pub-id>
<pub-id pub-id-type="pmid">1436694</pub-id>
</element-citation>
</ref>
<ref id="B129-viruses-11-00966">
<label>129.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Castellani</surname>
<given-names>R.J.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>H.-G.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Perry</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>M.A.</given-names>
</name>
</person-group>
<article-title>Alzheimer disease pathology as a host response</article-title>
<source/>J. Neuropathol. Exp. Neurol.
          <year>2008</year>
<volume>67</volume>
<fpage>523</fpage>
<lpage>531</lpage>
<pub-id pub-id-type="doi">10.1097/NEN.0b013e318177eaf4</pub-id>
<pub-id pub-id-type="pmid">18520771</pub-id>
</element-citation>
</ref>
<ref id="B130-viruses-11-00966">
<label>130.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Benditt</surname>
<given-names>E.P.</given-names>
</name>
<name>
<surname>Barrett</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>McDougall</surname>
<given-names>J.K.</given-names>
</name>
</person-group>
<article-title>Viruses in the etiology of atherosclerosis</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>1983</year>
<volume>80</volume>
<fpage>6386</fpage>
<lpage>6389</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.80.20.6386</pub-id>
<pub-id pub-id-type="pmid">6312457</pub-id>
</element-citation>
</ref>
<ref id="B131-viruses-11-00966">
<label>131.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gyorkey</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Melnick</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Guinn</surname>
<given-names>G.A.</given-names>
</name>
<name>
<surname>Gyorkey</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>DeBakey</surname>
<given-names>M.E.</given-names>
</name>
</person-group>
<article-title>Herpesviridae in the endothelial and smooth muscle cells of the proximal aorta in arteriosclerotic patients</article-title>
<source/>Exp. Mol. Pathol.
          <year>1984</year>
<volume>40</volume>
<fpage>328</fpage>
<lpage>339</lpage>
<pub-id pub-id-type="doi">10.1016/0014-4800(84)90050-9</pub-id>
<pub-id pub-id-type="pmid">6723937</pub-id>
</element-citation>
</ref>
<ref id="B132-viruses-11-00966">
<label>132.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yamashiroya</surname>
<given-names>H.M.</given-names>
</name>
<name>
<surname>Ghosh</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Robertson</surname>
<given-names>A.L.</given-names>
<suffix>Jr.</suffix>
</name>
</person-group>
<article-title>Herpesviridae in the coronary arteries and aorta of young trauma victims</article-title>
<source/>Am. J. Pathol.
          <year>1988</year>
<volume>130</volume>
<fpage>71</fpage>
<pub-id pub-id-type="pmid">2827495</pub-id>
</element-citation>
</ref>
<ref id="B133-viruses-11-00966">
<label>133.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Linnavuori</surname>
<given-names>K.H.</given-names>
</name>
</person-group>
<article-title>History of recurrent mucocutaneous herpes correlates with relatively low interferon production by herpes simplex virus-exposed cultured monocytes</article-title>
<source/>J. Med. Virol.
          <year>1988</year>
<volume>25</volume>
<fpage>61</fpage>
<lpage>68</lpage>
<pub-id pub-id-type="doi">10.1002/jmv.1890250109</pub-id>
<pub-id pub-id-type="pmid">2842448</pub-id>
</element-citation>
</ref>
<ref id="B134-viruses-11-00966">
<label>134.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roivainen</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Viik-Kajander</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Palosuo</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Toivanen</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Leinonen</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Saikku</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Tenkanen</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Manninen</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Hovi</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Mänttäri</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Infections, inflammation, and the risk of coronary heart disease</article-title>
<source/>Circulation
          <year>2000</year>
<volume>101</volume>
<fpage>252</fpage>
<lpage>257</lpage>
<pub-id pub-id-type="doi">10.1161/01.CIR.101.3.252</pub-id>
<pub-id pub-id-type="pmid">10645920</pub-id>
</element-citation>
</ref>
<ref id="B135-viruses-11-00966">
<label>135.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Siscovick</surname>
<given-names>D.S.</given-names>
</name>
<name>
<surname>Schwartz</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Corey</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Grayston</surname>
<given-names>J.T.</given-names>
</name>
<name>
<surname>Ashley</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>S.P.</given-names>
</name>
<name>
<surname>Psaty</surname>
<given-names>B.M.</given-names>
</name>
<name>
<surname>Tracy</surname>
<given-names>R.P.</given-names>
</name>
<name>
<surname>Kuller</surname>
<given-names>L.H.</given-names>
</name>
<name>
<surname>Kronmal</surname>
<given-names>R.A.</given-names>
</name>
</person-group>
<article-title>Chlamydia pneumoniae, herpes simplex virus type 1, and cytomegalovirus and incident myocardial infarction and coronary heart disease death in older adults: The Cardiovascular Health Study</article-title>
<source/>Circulation
          <year>2000</year>
<volume>102</volume>
<fpage>2335</fpage>
<lpage>2340</lpage>
<pub-id pub-id-type="doi">10.1161/01.CIR.102.19.2335</pub-id>
<pub-id pub-id-type="pmid">11067785</pub-id>
</element-citation>
</ref>
<ref id="B136-viruses-11-00966">
<label>136.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Vankirk</surname>
<given-names>C.A.</given-names>
</name>
</person-group>
<article-title>Characterization and Regulation of the Major Histocompatibility Complex Class I in the Cns: Functional Implications for Brain Aging and Sexually Dimorphic Differences in Neuroinflammation</article-title>
<source/>Ph.D. Thesis
          <publisher-name>Pennsylvania State University</publisher-name>
<publisher-loc>Centre County, PA, USA</publisher-loc>
<year>2013</year>
</element-citation>
</ref>
<ref id="B137-viruses-11-00966">
<label>137.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Popescu</surname>
<given-names>B.O.</given-names>
</name>
<name>
<surname>Toescu</surname>
<given-names>E.C.</given-names>
</name>
<name>
<surname>Popescu</surname>
<given-names>L.M.</given-names>
</name>
<name>
<surname>Bajenaru</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Muresanu</surname>
<given-names>D.F.</given-names>
</name>
<name>
<surname>Schultzberg</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bogdanovic</surname>
<given-names>N.</given-names>
</name>
</person-group>
<article-title>Blood-brain barrier alterations in ageing and dementia</article-title>
<source/>J. Neurol. Sci.
          <year>2009</year>
<volume>283</volume>
<fpage>99</fpage>
<lpage>106</lpage>
<pub-id pub-id-type="doi">10.1016/j.jns.2009.02.321</pub-id>
<pub-id pub-id-type="pmid">19264328</pub-id>
</element-citation>
</ref>
<ref id="B138-viruses-11-00966">
<label>138.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weiskopf</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Weinberger</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Grubeck-Loebenstein</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>The aging of the immune system</article-title>
<source/>Transpl. Int.
          <year>2009</year>
<volume>22</volume>
<fpage>1041</fpage>
<lpage>1050</lpage>
<pub-id pub-id-type="doi">10.1111/j.1432-2277.2009.00927.x</pub-id>
<pub-id pub-id-type="pmid">19624493</pub-id>
</element-citation>
</ref>
<ref id="B139-viruses-11-00966">
<label>139.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stowe</surname>
<given-names>R.P.</given-names>
</name>
<name>
<surname>Kozlova</surname>
<given-names>E.V.</given-names>
</name>
<name>
<surname>Yetman</surname>
<given-names>D.L.</given-names>
</name>
<name>
<surname>Walling</surname>
<given-names>D.M.</given-names>
</name>
<name>
<surname>Goodwin</surname>
<given-names>J.S.</given-names>
</name>
<name>
<surname>Glaser</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Chronic herpesvirus reactivation occurs in aging</article-title>
<source/>Exp. Gerontol.
          <year>2007</year>
<volume>42</volume>
<fpage>563</fpage>
<lpage>570</lpage>
<pub-id pub-id-type="doi">10.1016/j.exger.2007.01.005</pub-id>
<pub-id pub-id-type="pmid">17337145</pub-id>
</element-citation>
</ref>
<ref id="B140-viruses-11-00966">
<label>140.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ershler</surname>
<given-names>W.B.</given-names>
</name>
</person-group>
<article-title>Interleukin-6: A cytokine for gerontologists</article-title>
<source/>J. Am. Geriatr. Soc.
          <year>1993</year>
<volume>41</volume>
<fpage>176</fpage>
<lpage>181</lpage>
<pub-id pub-id-type="doi">10.1111/j.1532-5415.1993.tb02054.x</pub-id>
<pub-id pub-id-type="pmid">8426042</pub-id>
</element-citation>
</ref>
<ref id="B141-viruses-11-00966">
<label>141.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saldanha</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sutton</surname>
<given-names>R.N.</given-names>
</name>
<name>
<surname>Gannicliffe</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Farragher</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Itzhaki</surname>
<given-names>R.F.</given-names>
</name>
</person-group>
<article-title>Detection of HSV1 DNA by in situ hybridisation in human brain after immunosuppression</article-title>
<source/>J. Neurol. Neurosurg. Psychiatry
          <year>1986</year>
<volume>49</volume>
<fpage>613</fpage>
<lpage>619</lpage>
<pub-id pub-id-type="doi">10.1136/jnnp.49.6.613</pub-id>
<pub-id pub-id-type="pmid">3016195</pub-id>
</element-citation>
</ref>
<ref id="B142-viruses-11-00966">
<label>142.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cheon</surname>
<given-names>M.S.</given-names>
</name>
<name>
<surname>Bajo</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gulesserian</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Cairns</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Lubec</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Evidence for the relation of herpes simplex virus type 1 to Down syndrome and Alzheimer’s disease</article-title>
<source/>Electrophoresis
          <year>2001</year>
<volume>22</volume>
<fpage>445</fpage>
<lpage>448</lpage>
<pub-id pub-id-type="doi">10.1002/1522-2683(200102)22:3&lt;445::AID-ELPS445&gt;3.0.CO;2-8</pub-id>
<pub-id pub-id-type="pmid">11258753</pub-id>
</element-citation>
</ref>
<ref id="B143-viruses-11-00966">
<label>143.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Itzhaki</surname>
<given-names>R.F.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>W.R.</given-names>
</name>
<name>
<surname>Shang</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Wilcock</surname>
<given-names>G.K.</given-names>
</name>
<name>
<surname>Faragher</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Jamieson</surname>
<given-names>G.A.</given-names>
</name>
</person-group>
<article-title>Herpes simplex virus type 1 in brain and risk of Alzheimer’s disease</article-title>
<source/>Lancet
          <year>1997</year>
<volume>349</volume>
<fpage>241</fpage>
<lpage>244</lpage>
<pub-id pub-id-type="doi">10.1016/S0140-6736(96)10149-5</pub-id>
<pub-id pub-id-type="pmid">9014911</pub-id>
</element-citation>
</ref>
<ref id="B144-viruses-11-00966">
<label>144.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jamieson</surname>
<given-names>G.A.</given-names>
</name>
<name>
<surname>Maitland</surname>
<given-names>N.J.</given-names>
</name>
<name>
<surname>Wilcock</surname>
<given-names>G.K.</given-names>
</name>
<name>
<surname>Craske</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Itzhaki</surname>
<given-names>R.F.</given-names>
</name>
</person-group>
<article-title>Latent herpes simplex virus type 1 in normal and Alzheimer’s disease brains</article-title>
<source/>J. Med. Virol.
          <year>1991</year>
<volume>33</volume>
<fpage>224</fpage>
<lpage>227</lpage>
<pub-id pub-id-type="doi">10.1002/jmv.1890330403</pub-id>
<pub-id pub-id-type="pmid">1649907</pub-id>
</element-citation>
</ref>
<ref id="B145-viruses-11-00966">
<label>145.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jamieson</surname>
<given-names>G.A.</given-names>
</name>
<name>
<surname>Maitland</surname>
<given-names>N.J.</given-names>
</name>
<name>
<surname>Wilcock</surname>
<given-names>G.K.</given-names>
</name>
<name>
<surname>Yates</surname>
<given-names>C.M.</given-names>
</name>
<name>
<surname>Itzhaki</surname>
<given-names>R.F.</given-names>
</name>
</person-group>
<article-title>Herpes simplex virus type 1 DNA is present in specific regions of brain from aged people with and without senile dementia of the Alzheimer type</article-title>
<source/>J. Pathol.
          <year>1992</year>
<volume>167</volume>
<fpage>365</fpage>
<lpage>368</lpage>
<pub-id pub-id-type="doi">10.1002/path.1711670403</pub-id>
<pub-id pub-id-type="pmid">1328575</pub-id>
</element-citation>
</ref>
<ref id="B146-viruses-11-00966">
<label>146.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jamieson</surname>
<given-names>G.A.</given-names>
</name>
<name>
<surname>Maitland</surname>
<given-names>N.J.</given-names>
</name>
<name>
<surname>Craske</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wilcock</surname>
<given-names>G.K.</given-names>
</name>
<name>
<surname>Itzhaki</surname>
<given-names>R.F.</given-names>
</name>
</person-group>
<article-title>Detection of herpes simplex virus type 1 DNA sequences in normal and Alzheimer’s disease brain using polymerase chain reaction</article-title>
<source/>Biochem. Soc. Trans.
          <year>1991</year>
<volume>19</volume>
<fpage>122S</fpage>
<pub-id pub-id-type="doi">10.1042/bst019122s</pub-id>
<pub-id pub-id-type="pmid">1653719</pub-id>
</element-citation>
</ref>
<ref id="B147-viruses-11-00966">
<label>147.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wozniak</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Shipley</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Combrinck</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wilcock</surname>
<given-names>G.K.</given-names>
</name>
<name>
<surname>Itzhaki</surname>
<given-names>R.F.</given-names>
</name>
</person-group>
<article-title>Productive herpes simplex virus in brain of elderly normal subjects and Alzheimer’s disease patients</article-title>
<source/>J. Med. Virol.
          <year>2005</year>
<volume>75</volume>
<fpage>300</fpage>
<lpage>306</lpage>
<pub-id pub-id-type="doi">10.1002/jmv.20271</pub-id>
<pub-id pub-id-type="pmid">15602731</pub-id>
</element-citation>
</ref>
<ref id="B148-viruses-11-00966">
<label>148.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ball</surname>
<given-names>M.J.</given-names>
</name>
</person-group>
<article-title>Limbic predilection in Alzheimer dementia: Is reactivated herpesvirus involved?</article-title>
<source/>Can. J. Neurol. Sci.
          <year>1982</year>
<volume>9</volume>
<fpage>303</fpage>
<lpage>306</lpage>
<pub-id pub-id-type="doi">10.1017/S0317167100044115</pub-id>
<pub-id pub-id-type="pmid">7116237</pub-id>
</element-citation>
</ref>
<ref id="B149-viruses-11-00966">
<label>149.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nicoll</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Love</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kinrade</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Distribution of herpes simplex virus DNA in the brains of human long-term survivors of encephalitis</article-title>
<source/>Neurosci. Lett.
          <year>1993</year>
<volume>157</volume>
<fpage>215</fpage>
<lpage>218</lpage>
<pub-id pub-id-type="doi">10.1016/0304-3940(93)90740-C</pub-id>
<pub-id pub-id-type="pmid">8233057</pub-id>
</element-citation>
</ref>
<ref id="B150-viruses-11-00966">
<label>150.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wozniak</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mee</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Itzhaki</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Herpes simplex virus type 1 DNA is located within Alzheimer’s disease amyloid plaques</article-title>
<source/>J. Pathol.
          <year>2009</year>
<volume>217</volume>
<fpage>131</fpage>
<lpage>138</lpage>
<pub-id pub-id-type="doi">10.1002/path.2449</pub-id>
<pub-id pub-id-type="pmid">18973185</pub-id>
</element-citation>
</ref>
<ref id="B151-viruses-11-00966">
<label>151.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hemling</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Röyttä</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Rinne</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Pöllänen</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Broberg</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Tapio</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Vahlberg</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Hukkanen</surname>
<given-names>V.</given-names>
</name>
</person-group>
<article-title>Herpesviruses in brains in Alzheimer’s and Parkinson’s diseases</article-title>
<source/>Ann. Neurol.
          <year>2003</year>
<volume>54</volume>
<fpage>267</fpage>
<lpage>271</lpage>
<pub-id pub-id-type="doi">10.1002/ana.10662</pub-id>
<pub-id pub-id-type="pmid">12891684</pub-id>
</element-citation>
</ref>
<ref id="B152-viruses-11-00966">
<label>152.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marques</surname>
<given-names>A.R.</given-names>
</name>
<name>
<surname>Straus</surname>
<given-names>S.E.</given-names>
</name>
<name>
<surname>Fahle</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Weir</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Csako</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Fischer</surname>
<given-names>S.H.</given-names>
</name>
</person-group>
<article-title>Lack of association between HSV-1 DNA in the brain, Alzheimer’s disease and apolipoprotein Ejournal</article-title>
<source/>Neurovirology
          <year>2001</year>
<volume>7</volume>
<fpage>82</fpage>
<lpage>83</lpage>
</element-citation>
</ref>
<ref id="B153-viruses-11-00966">
<label>153.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wozniak</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Itzhaki</surname>
<given-names>R.F.</given-names>
</name>
<name>
<surname>Shipley</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Dobson</surname>
<given-names>C.B.</given-names>
</name>
</person-group>
<article-title>Herpes simplex virus infection causes cellular beta-amyloid accumulation and secretase upregulation</article-title>
<source/>Neurosci. Lett.
          <year>2007</year>
<volume>429</volume>
<fpage>95</fpage>
<lpage>100</lpage>
<pub-id pub-id-type="doi">10.1016/j.neulet.2007.09.077</pub-id>
<pub-id pub-id-type="pmid">17980964</pub-id>
</element-citation>
</ref>
<ref id="B154-viruses-11-00966">
<label>154.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li Puma</surname>
<given-names>D.D.</given-names>
</name>
<name>
<surname>Piacentini</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Leone</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Gironi</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Marcocci</surname>
<given-names>M.E.</given-names>
</name>
<name>
<surname>Chiara</surname>
<given-names>G.D.</given-names>
</name>
<name>
<surname>Palamara</surname>
<given-names>A.T.</given-names>
</name>
<name>
<surname>Grassi</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Herpes Simplex Virus Type-1 Infection Impairs Adult Hippocampal Neurogenesis via Amyloid-β Protein Accumulation: Herpes Simplex Virus Impairs Adult Neurogenesis</article-title>
<source/>Stem Cells
          <year>2019</year>
<pub-id pub-id-type="doi">10.1002/stem.3072</pub-id>
</element-citation>
</ref>
<ref id="B155-viruses-11-00966">
<label>155.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alvarez</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Aldudo</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Alonso</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Santana</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Valdivieso</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Herpes simplex virus type 1 induces nuclear accumulation of hyperphosphorylated tau in neuronal cells</article-title>
<source/>J. Neurosci. Res.
          <year>2012</year>
<volume>90</volume>
<fpage>1020</fpage>
<lpage>1029</lpage>
<pub-id pub-id-type="doi">10.1002/jnr.23003</pub-id>
<pub-id pub-id-type="pmid">22252837</pub-id>
</element-citation>
</ref>
<ref id="B156-viruses-11-00966">
<label>156.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wozniak</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Frost</surname>
<given-names>A.L.</given-names>
</name>
<name>
<surname>Itzhaki</surname>
<given-names>R.F.</given-names>
</name>
</person-group>
<article-title>Alzheimer’s disease-specific tau phosphorylation is induced by herpes simplex virus type 1</article-title>
<source/>J. Alzheimers Dis.
          <year>2009</year>
<volume>16</volume>
<fpage>341</fpage>
<lpage>350</lpage>
<pub-id pub-id-type="doi">10.3233/JAD-2009-0963</pub-id>
<pub-id pub-id-type="pmid">19221424</pub-id>
</element-citation>
</ref>
<ref id="B157-viruses-11-00966">
<label>157.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zambrano</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Solis</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Salvadores</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Cortés</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lerchundi</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Otth</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Neuronal cytoskeletal dynamic modification and neurodegeneration induced by infection with herpes simplex virus type 1</article-title>
<source/>J. Alzheimers Dis.
          <year>2008</year>
<volume>14</volume>
<fpage>259</fpage>
<lpage>269</lpage>
<pub-id pub-id-type="doi">10.3233/JAD-2008-14301</pub-id>
<pub-id pub-id-type="pmid">18599953</pub-id>
</element-citation>
</ref>
<ref id="B158-viruses-11-00966">
<label>158.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martin</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Aguila</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Araya</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Vio</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Valdivia</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zambrano</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Concha</surname>
<given-names>M.I.</given-names>
</name>
<name>
<surname>Otth</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Inflammatory and neurodegeneration markers during asymptomatic HSV-1 reactivation</article-title>
<source/>J. Alzheimers Dis.
          <year>2014</year>
<volume>39</volume>
<fpage>849</fpage>
<lpage>859</lpage>
<pub-id pub-id-type="doi">10.3233/JAD-131706</pub-id>
<pub-id pub-id-type="pmid">24296813</pub-id>
</element-citation>
</ref>
<ref id="B159-viruses-11-00966">
<label>159.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shimeld</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Whiteland</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Nicholls</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Grinfeld</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Easty</surname>
<given-names>D.L.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Hill</surname>
<given-names>T.J.</given-names>
</name>
</person-group>
<article-title>Immune cell infiltration and persistence in the mouse trigeminal ganglion after infection of the cornea with herpes simplex virus type 1</article-title>
<source/>J. Neuroimmunol.
          <year>1995</year>
<volume>61</volume>
<fpage>7</fpage>
<lpage>16</lpage>
<pub-id pub-id-type="doi">10.1016/0165-5728(95)00068-D</pub-id>
<pub-id pub-id-type="pmid">7560014</pub-id>
</element-citation>
</ref>
<ref id="B160-viruses-11-00966">
<label>160.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shimeld</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Whiteland</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>N.A.</given-names>
</name>
<name>
<surname>Easty</surname>
<given-names>D.L.</given-names>
</name>
<name>
<surname>Hill</surname>
<given-names>T.J.</given-names>
</name>
</person-group>
<article-title>Cytokine production in the nervous system of mice during acute and latent infection with herpes simplex virus type 1</article-title>
<source/>J. Gen. Virol.
          <year>1997</year>
<volume>78</volume>
<issue-part>Pt 12</issue-part>
<fpage>3317</fpage>
<lpage>3325</lpage>
<pub-id pub-id-type="doi">10.1099/0022-1317-78-12-3317</pub-id>
<pub-id pub-id-type="pmid">9400983</pub-id>
</element-citation>
</ref>
<ref id="B161-viruses-11-00966">
<label>161.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Szpara</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>Kobiler</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Enquist</surname>
<given-names>L.W.</given-names>
</name>
</person-group>
<article-title>A common neuronal response to alphaherpesvirus infection</article-title>
<source/>J. Neuroimmune Pharmacol.
          <year>2010</year>
<volume>5</volume>
<fpage>418</fpage>
<lpage>427</lpage>
<pub-id pub-id-type="doi">10.1007/s11481-010-9212-0</pub-id>
<pub-id pub-id-type="pmid">20401540</pub-id>
</element-citation>
</ref>
<ref id="B162-viruses-11-00966">
<label>162.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bowen</surname>
<given-names>C.D.</given-names>
</name>
<name>
<surname>Paavilainen</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Renner</surname>
<given-names>D.W.</given-names>
</name>
<name>
<surname>Palomäki</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lehtinen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Vuorinen</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Norberg</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Hukkanen</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Szpara</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>HSV-1 strains circulating in Finland demonstrate uncoupling of geographic and phenotypic variation</article-title>
<source/>J. Virol.
          <year>2018</year>
<volume>93</volume>
<fpage>e01824-18</fpage>
<pub-id pub-id-type="doi">10.1128/jvi.01824-18</pub-id>
</element-citation>
</ref>
<ref id="B163-viruses-11-00966">
<label>163.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bower</surname>
<given-names>J.R.</given-names>
</name>
<name>
<surname>Mao</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Durishin</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Rozenbom</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Detwiler</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Rempinski</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Karban</surname>
<given-names>T.L.</given-names>
</name>
<name>
<surname>Rosenthal</surname>
<given-names>K.S.</given-names>
</name>
</person-group>
<article-title>Intrastrain variants of herpes simplex virus type 1 isolated from a neonate with fatal disseminated infection differ in the ICP34.5 gene, glycoprotein processing, and neuroinvasiveness</article-title>
<source/>J. Virol.
          <year>1999</year>
<volume>73</volume>
<fpage>3843</fpage>
<lpage>3853</lpage>
<pub-id pub-id-type="pmid">10196279</pub-id>
</element-citation>
</ref>
<ref id="B164-viruses-11-00966">
<label>164.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mao</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Rosenthal</surname>
<given-names>K.S.</given-names>
</name>
</person-group>
<article-title>Strain-Dependent Structural Variants of Herpes Simplex Virus Type 1 ICP34.5 Determine Viral Plaque Size, Efficiency of Glycoprotein Processing, and Viral Release and Neuroinvasive Disease Potential</article-title>
<source/>J. Virol.
          <year>2003</year>
<volume>77</volume>
<fpage>3409</fpage>
<lpage>3417</lpage>
<pub-id pub-id-type="doi">10.1128/JVI.77.6.3409-3417.2003</pub-id>
<pub-id pub-id-type="pmid">12610116</pub-id>
</element-citation>
</ref>
<ref id="B165-viruses-11-00966">
<label>165.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Velandia</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>Castellanos</surname>
<given-names>J.E.</given-names>
</name>
</person-group>
<article-title>Flavivirus Neurotropism, Neuroinvasion, Neurovirulence and Neurosusceptibility: Clues to Understanding Flavivirus- and Dengue-Induced Encephalitis</article-title>
<source/>Viral Genomes Mol. Struct. Divers. Gene Expr. Mech. Host Virus Interact.
          <year>2012</year>
<pub-id pub-id-type="doi">10.5772/26571</pub-id>
</element-citation>
</ref>
<ref id="B166-viruses-11-00966">
<label>166.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stroop</surname>
<given-names>W.G.</given-names>
</name>
<name>
<surname>Schaefer</surname>
<given-names>D.C.</given-names>
</name>
</person-group>
<article-title>Severity of experimentally reactivated herpetic eye disease is related to the neurovirulence of the latent virus</article-title>
<source/>Invest. Ophthalmol. Vis. Sci.
          <year>1987</year>
<volume>28</volume>
<fpage>229</fpage>
<lpage>237</lpage>
<pub-id pub-id-type="pmid">8591901</pub-id>
</element-citation>
</ref>
<ref id="B167-viruses-11-00966">
<label>167.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kolb</surname>
<given-names>A.W.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Larsen</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Craven</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Brandt</surname>
<given-names>C.R.</given-names>
</name>
</person-group>
<article-title>Quantitative Trait Locus Based Virulence Determinant Mapping of the HSV-1 Genome in Murine Ocular Infection: Genes Involved in Viral Regulatory and Innate Immune Networks Contribute to Virulence</article-title>
<source/>PLoS Pathog.
          <year>2016</year>
<volume>12</volume>
<elocation-id>e1005499</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.ppat.1005499</pub-id>
<pub-id pub-id-type="pmid">26962864</pub-id>
</element-citation>
</ref>
<ref id="B168-viruses-11-00966">
<label>168.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hill</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Rayfield</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Haruta</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Strain specificity of spontaneous and adrenergically induced HSV-1 ocular reactivation in latently infected rabbits</article-title>
<source/>Curr. Eye Res.
          <year>1987</year>
<volume>6</volume>
<fpage>91</fpage>
<lpage>97</lpage>
<pub-id pub-id-type="doi">10.3109/02713688709020074</pub-id>
<pub-id pub-id-type="pmid">3030660</pub-id>
</element-citation>
</ref>
<ref id="B169-viruses-11-00966">
<label>169.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chowdhury</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Naderi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Chouljenko</surname>
<given-names>V.N.</given-names>
</name>
<name>
<surname>Walker</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>Kousoulas</surname>
<given-names>K.G.</given-names>
</name>
</person-group>
<article-title>Amino acid differences in glycoproteins B (gB), C (gC), H (gH) and L (gL) are associated with enhanced herpes simplex virus type-1 (McKrae) entry via the paired immunoglobulin-like type-2 receptor α</article-title>
<source/>Virol. J.
          <year>2012</year>
<volume>9</volume>
<fpage>1</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1186/1743-422X-9-112</pub-id>
<pub-id pub-id-type="pmid">22214262</pub-id>
</element-citation>
</ref>
<ref id="B170-viruses-11-00966">
<label>170.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Watson</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Reed</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Babra</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Putman</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Wick</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Wechsler</surname>
<given-names>S.L.</given-names>
</name>
<name>
<surname>Rohrmann</surname>
<given-names>G.F.</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Sequence and comparative analysis of the genome of HSV-1 strain McKrae</article-title>
<source/>Virology
          <year>2012</year>
<volume>433</volume>
<fpage>528</fpage>
<lpage>537</lpage>
<pub-id pub-id-type="doi">10.1016/j.virol.2012.08.043</pub-id>
<pub-id pub-id-type="pmid">23021301</pub-id>
</element-citation>
</ref>
<ref id="B171-viruses-11-00966">
<label>171.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perng</surname>
<given-names>G.-C.</given-names>
</name>
<name>
<surname>Mott</surname>
<given-names>K.R.</given-names>
</name>
<name>
<surname>Osorio</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Yukht</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Salina</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Nguyen</surname>
<given-names>Q.-H.</given-names>
</name>
<name>
<surname>Nesburn</surname>
<given-names>A.B.</given-names>
</name>
<name>
<surname>Wechsler</surname>
<given-names>S.L.</given-names>
</name>
</person-group>
<article-title>Herpes simplex virus type 1 mutants containing the KOS strain ICP34.5 gene in place of the McKrae ICP34.5 gene have McKrae-like spontaneous reactivation but non-McKrae-like virulence</article-title>
<source/>J. Gen. Virol.
          <year>2002</year>
<volume>83</volume>
<fpage>2933</fpage>
<lpage>2942</lpage>
<pub-id pub-id-type="doi">10.1099/0022-1317-83-12-2933</pub-id>
<pub-id pub-id-type="pmid">12466469</pub-id>
</element-citation>
</ref>
<ref id="B172-viruses-11-00966">
<label>172.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bolovan</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Sawtell</surname>
<given-names>N.M.</given-names>
</name>
<name>
<surname>Thompson</surname>
<given-names>R.L.</given-names>
</name>
</person-group>
<article-title>ICP34.5 mutants of herpes simplex virus type 1 strain 17syn+ are attenuated for neurovirulence in mice and for replication in confluent primary mouse embryo cell cultures</article-title>
<source/>J. Virol.
          <year>1994</year>
<volume>68</volume>
<fpage>48</fpage>
<lpage>55</lpage>
<pub-id pub-id-type="pmid">8254758</pub-id>
</element-citation>
</ref>
<ref id="B173-viruses-11-00966">
<label>173.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>B.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>ICP34.5 Protein of Herpes Simplex Virus Facilitates the Initiation of Protein Translation by Bridging Eukaryotic Initiation Factor 2α (eIF2α) and Protein Phosphatase</article-title>
<source/>J. Biol. Chem.
          <year>2011</year>
<volume>286</volume>
<fpage>24785</fpage>
<lpage>24792</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M111.232439</pub-id>
<pub-id pub-id-type="pmid">21622569</pub-id>
</element-citation>
</ref>
<ref id="B174-viruses-11-00966">
<label>174.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Orvedahl</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Alexander</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Tallóczy</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Burns</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Leib</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Levine</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>HSV-1 ICP34.5 Confers Neurovirulence by Targeting the Beclin 1 Autophagy Protein</article-title>
<source/>Cell Host Microbe
          <year>2007</year>
<volume>1</volume>
<fpage>23</fpage>
<lpage>35</lpage>
<pub-id pub-id-type="doi">10.1016/j.chom.2006.12.001</pub-id>
<pub-id pub-id-type="pmid">18005679</pub-id>
</element-citation>
</ref>
<ref id="B175-viruses-11-00966">
<label>175.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perng</surname>
<given-names>G.C.</given-names>
</name>
<name>
<surname>Thompson</surname>
<given-names>R.L.</given-names>
</name>
<name>
<surname>Sawtell</surname>
<given-names>N.M.</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>W.E.</given-names>
</name>
<name>
<surname>Slanina</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Ghiasi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Kaiwar</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Nesburn</surname>
<given-names>A.B.</given-names>
</name>
<name>
<surname>Wechsler</surname>
<given-names>S.L.</given-names>
</name>
</person-group>
<article-title>An avirulent ICP34.5 deletion mutant of herpes simplex virus type 1 is capable of in vivo spontaneous reactivation</article-title>
<source/>J. Virol.
          <year>1995</year>
<volume>69</volume>
<fpage>3033</fpage>
<lpage>3041</lpage>
<pub-id pub-id-type="pmid">7707530</pub-id>
</element-citation>
</ref>
<ref id="B176-viruses-11-00966">
<label>176.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mao</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Rosenthal</surname>
<given-names>K.S.</given-names>
</name>
</person-group>
<article-title>An N-terminal Arginine-rich Cluster and a Proline-Alanine-Threonine Repeat Region Determine the Cellular Localization of the Herpes Simplex Virus Type 1 ICP34.5 Protein and Its Ligand, Protein Phosphatase</article-title>
<source/>J. Biol. Chem.
          <year>2002</year>
<volume>277</volume>
<fpage>11423</fpage>
<lpage>11431</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M111553200</pub-id>
<pub-id pub-id-type="pmid">11788604</pub-id>
</element-citation>
</ref>
<ref id="B177-viruses-11-00966">
<label>177.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eimer</surname>
<given-names>W.A.</given-names>
</name>
<name>
<surname>Vijaya Kumar</surname>
<given-names>D.K.</given-names>
</name>
<name>
<surname>Navalpur Shanmugam</surname>
<given-names>N.K.</given-names>
</name>
<name>
<surname>Rodriguez</surname>
<given-names>A.S.</given-names>
</name>
<name>
<surname>Mitchell</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Washicosky</surname>
<given-names>K.J.</given-names>
</name>
<name>
<surname>György</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Breakefield</surname>
<given-names>X.O.</given-names>
</name>
<name>
<surname>Tanzi</surname>
<given-names>R.E.</given-names>
</name>
<name>
<surname>Moir</surname>
<given-names>R.D.</given-names>
</name>
</person-group>
<article-title>Alzheimer’s Disease-Associated β-Amyloid Is Rapidly Seeded by Herpesviridae to Protect against Brain Infection</article-title>
<source/>Neuron
          <year>2018</year>
<volume>99</volume>
<fpage>56</fpage>
<lpage>63.e3</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2018.06.030</pub-id>
<pub-id pub-id-type="pmid">30001512</pub-id>
</element-citation>
</ref>
<ref id="B178-viruses-11-00966">
<label>178.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ezzat</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Pernemalm</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Pålsson</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Roberts</surname>
<given-names>T.C.</given-names>
</name>
<name>
<surname>Järver</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Dondalska</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bestas</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Sobkowiak</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Levänen</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Sköld</surname>
<given-names>M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The viral protein corona directs viral pathogenesis and amyloid aggregation</article-title>
<source/>Nat. Commun.
          <year>2019</year>
<volume>10</volume>
<fpage>2331</fpage>
<pub-id pub-id-type="doi">10.1038/s41467-019-10192-2</pub-id>
<pub-id pub-id-type="pmid">31133680</pub-id>
</element-citation>
</ref>
<ref id="B179-viruses-11-00966">
<label>179.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cheng</surname>
<given-names>S.-B.</given-names>
</name>
<name>
<surname>Ferland</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Webster</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Bearer</surname>
<given-names>E.L.</given-names>
</name>
</person-group>
<article-title>Herpes Simplex Virus Dances with Amyloid Precursor Protein while Exiting the Cell</article-title>
<source/>PLoS ONE
          <year>2011</year>
<volume>6</volume>
<elocation-id>e17966</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0017966</pub-id>
<pub-id pub-id-type="pmid">21483850</pub-id>
</element-citation>
</ref>
<ref id="B180-viruses-11-00966">
<label>180.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Santana</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Recuero</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bullido</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Valdivieso</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Aldudo</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Herpes simplex virus type I induces the accumulation of intracellular β-amyloid in autophagic compartments and the inhibition of the non-amyloidogenic pathway in human neuroblastoma cells</article-title>
<source/>Neurobiol. Aging
          <year>2012</year>
<volume>33</volume>
<fpage>430.e19</fpage>
<lpage>430.e33</lpage>
<pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2010.12.010</pub-id>
</element-citation>
</ref>
<ref id="B181-viruses-11-00966">
<label>181.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bourgade</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Garneau</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Giroux</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Le Page</surname>
<given-names>A.Y.</given-names>
</name>
<name>
<surname>Bocti</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Dupuis</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Frost</surname>
<given-names>E.H.</given-names>
</name>
<name>
<surname>Fülöp</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>β-Amyloid peptides display protective activity against the human Alzheimer’s disease-associated herpes simplex virus-1</article-title>
<source/>Biogerontology
          <year>2015</year>
<volume>16</volume>
<fpage>85</fpage>
<lpage>98</lpage>
<pub-id pub-id-type="doi">10.1007/s10522-014-9538-8</pub-id>
<pub-id pub-id-type="pmid">25376108</pub-id>
</element-citation>
</ref>
<ref id="B182-viruses-11-00966">
<label>182.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bourgade</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Le Page</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bocti</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Witkowski</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Dupuis</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Frost</surname>
<given-names>E.H.</given-names>
</name>
<name>
<surname>Fueloep</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Protective Effect of Amyloid-beta Peptides Against Herpes Simplex Virus-1 Infection in a Neuronal Cell Culture Model</article-title>
<source/>J. Alzheimer’s Dis.
          <year>2016</year>
<volume>50</volume>
<fpage>1227</fpage>
<lpage>1241</lpage>
<pub-id pub-id-type="doi">10.3233/JAD-150652</pub-id>
<pub-id pub-id-type="pmid">26836158</pub-id>
</element-citation>
</ref>
<ref id="B183-viruses-11-00966">
<label>183.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rathore</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Ramani</surname>
<given-names>S.R.</given-names>
</name>
<name>
<surname>Pantua</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Payandeh</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Bhangale</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Wuster</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kapoor</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kapadia</surname>
<given-names>S.B.</given-names>
</name>
<name>
<surname>Gonzalez</surname>
<given-names>L.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Paired Immunoglobulin-like Type 2 Receptor Alpha G78R variant alters ligand binding and confers protection to Alzheimer’s disease</article-title>
<source/>PLoS Genet.
          <year>2018</year>
<volume>14</volume>
<elocation-id>e1007427</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pgen.1007427</pub-id>
<pub-id pub-id-type="pmid">30388101</pub-id>
</element-citation>
</ref>
<ref id="B184-viruses-11-00966">
<label>184.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dubin</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Socolof</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Frank</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Friedman</surname>
<given-names>H.M.</given-names>
</name>
</person-group>
<article-title>Herpes simplex virus type 1 Fc receptor protects infected cells from antibody-dependent cellular cytotoxicity</article-title>
<source/>J. Virol.
          <year>1991</year>
<volume>65</volume>
<fpage>7046</fpage>
<lpage>7050</lpage>
<pub-id pub-id-type="pmid">1658396</pub-id>
</element-citation>
</ref>
<ref id="B185-viruses-11-00966">
<label>185.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dubin</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Frank</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Friedman</surname>
<given-names>H.M.</given-names>
</name>
</person-group>
<article-title>Herpes simplex virus type 1 encodes two Fc receptors which have different binding characteristics for monomeric immunoglobulin G (IgG) and IgG complexes</article-title>
<source/>J. Virol.
          <year>1990</year>
<volume>64</volume>
<fpage>2725</fpage>
<lpage>2731</lpage>
<pub-id pub-id-type="pmid">2159540</pub-id>
</element-citation>
</ref>
<ref id="B186-viruses-11-00966">
<label>186.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Atherton</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Armour</surname>
<given-names>K.L.</given-names>
</name>
<name>
<surname>Bell</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Minson</surname>
<given-names>A.C.</given-names>
</name>
<name>
<surname>Clark</surname>
<given-names>M.R.</given-names>
</name>
</person-group>
<article-title>The herpes simplex virus type 1 Fc receptor discriminates between IgG1 allotypes</article-title>
<source/>Eur. J. Immunol.
          <year>2000</year>
<volume>30</volume>
<fpage>2540</fpage>
<lpage>2547</lpage>
<pub-id pub-id-type="doi">10.1002/1521-4141(200009)30:9&lt;2540::AID-IMMU2540&gt;3.0.CO;2-S</pub-id>
<pub-id pub-id-type="pmid">11009087</pub-id>
</element-citation>
</ref>
<ref id="B187-viruses-11-00966">
<label>187.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pandey</surname>
<given-names>J.P.</given-names>
</name>
</person-group>
<article-title>Immunoglobulin Genes and Immunity to Herpes Simplex Virus Type 1</article-title>
<source/>J. Infect. Dis
          <year>2012</year>
<volume>206</volume>
<fpage>143</fpage>
<lpage>144</lpage>
<pub-id pub-id-type="doi">10.1093/infdis/jis317</pub-id>
<pub-id pub-id-type="pmid">22535994</pub-id>
</element-citation>
</ref>
<ref id="B188-viruses-11-00966">
<label>188.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pandey</surname>
<given-names>J.P.</given-names>
</name>
<name>
<surname>Kothera</surname>
<given-names>R.T.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Costa</surname>
<given-names>A.S.</given-names>
</name>
<name>
<surname>Mancuso</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Agostini</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Immunoglobulin Genes and Immunity to HSV1 in Alzheimer’s Disease</article-title>
<source/>J. Alzheimer’s Dis.
          <year>2019</year>
<volume>70</volume>
<fpage>917</fpage>
<lpage>924</lpage>
<pub-id pub-id-type="doi">10.3233/JAD-190265</pub-id>
<pub-id pub-id-type="pmid">31306125</pub-id>
</element-citation>
</ref>
<ref id="B189-viruses-11-00966">
<label>189.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ball</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Lukiw</surname>
<given-names>W.J.</given-names>
</name>
<name>
<surname>Kammerman</surname>
<given-names>E.M.</given-names>
</name>
<name>
<surname>Hill</surname>
<given-names>J.M.</given-names>
</name>
</person-group>
<article-title>Intracerebral propagation of Alzheimer’s disease: Strengthening evidence of a herpes simplex virus etiology</article-title>
<source/>Alzheimer’s Dement.
          <year>2013</year>
<volume>9</volume>
<fpage>169</fpage>
<lpage>175</lpage>
<pub-id pub-id-type="doi">10.1016/j.jalz.2012.07.005</pub-id>
<pub-id pub-id-type="pmid">23159044</pub-id>
</element-citation>
</ref>
<ref id="B190-viruses-11-00966">
<label>190.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Castellano</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Stewart</surname>
<given-names>F.R.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>DeMattos</surname>
<given-names>R.B.</given-names>
</name>
<name>
<surname>Patterson</surname>
<given-names>B.W.</given-names>
</name>
<name>
<surname>Fagan</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Morris</surname>
<given-names>J.C.</given-names>
</name>
<name>
<surname>Mawuenyega</surname>
<given-names>K.G.</given-names>
</name>
<name>
<surname>Cruchaga</surname>
<given-names>C.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Human apoE isoforms differentially regulate brain amyloid-β peptide clearance</article-title>
<source/>Sci. Transl. Med.
          <year>2011</year>
<volume>3</volume>
<fpage>89ra57</fpage>
<pub-id pub-id-type="doi">10.1126/scitranslmed.3002156</pub-id>
<pub-id pub-id-type="pmid">21715678</pub-id>
</element-citation>
</ref>
<ref id="B191-viruses-11-00966">
<label>191.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Safieh</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Korczyn</surname>
<given-names>A.D.</given-names>
</name>
<name>
<surname>Michaelson</surname>
<given-names>D.M.</given-names>
</name>
</person-group>
<article-title>ApoE4: An emerging therapeutic target for Alzheimer’s disease</article-title>
<source/>BMC Med.
          <year>2019</year>
<volume>17</volume>
<elocation-id>64</elocation-id>
<pub-id pub-id-type="doi">10.1186/s12916-019-1299-4</pub-id>
<pub-id pub-id-type="pmid">30890171</pub-id>
</element-citation>
</ref>
<ref id="B192-viruses-11-00966">
<label>192.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lövheim</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Norman</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Weidung</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Olsson</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Josefsson</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Adolfsson</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Nyberg</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Elgh</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Herpes Simplex Virus, APOEε4, and Cognitive Decline in Old Age: Results from the Betula Cohort Study</article-title>
<source/>J. Alzheimers Dis.
          <year>2019</year>
<volume>67</volume>
<fpage>211</fpage>
<lpage>220</lpage>
<pub-id pub-id-type="doi">10.3233/JAD-171162</pub-id>
<pub-id pub-id-type="pmid">30636735</pub-id>
</element-citation>
</ref>
<ref id="B193-viruses-11-00966">
<label>193.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Burgos</surname>
<given-names>J.S.</given-names>
</name>
<name>
<surname>Ramirez</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Sastre</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Bullido</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Valdivieso</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>ApoE4 is more efficient than E3 in brain access by herpes simplex virus type 1</article-title>
<source/>Neuroreport
          <year>2003</year>
<volume>14</volume>
<fpage>1825</fpage>
<lpage>1827</lpage>
<pub-id pub-id-type="doi">10.1097/00001756-200310060-00013</pub-id>
<pub-id pub-id-type="pmid">14534428</pub-id>
</element-citation>
</ref>
<ref id="B194-viruses-11-00966">
<label>194.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Burgos</surname>
<given-names>J.S.</given-names>
</name>
<name>
<surname>Ramirez</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Sastre</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Valdivieso</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Effect of apolipoprotein E on the cerebral load of latent herpes simplex virus type 1 DNA</article-title>
<source/>J. Virol.
          <year>2006</year>
<volume>80</volume>
<fpage>5383</fpage>
<lpage>5387</lpage>
<pub-id pub-id-type="doi">10.1128/JVI.00006-06</pub-id>
<pub-id pub-id-type="pmid">16699018</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
<floats-group>
<fig id="viruses-11-00966-f001" orientation="portrait" position="float">
<label>Figure 1</label>
<caption>
<p>Persistent infection with herpes simplex virus 1 (HSV-1) and Alzheimer’s disease (AD): Opportunities for future research. Current evidence suggests that there is an association between HSV-1 infection and the development of AD later in life. However, a number of knowledge gaps exist in our understanding of the host- and virus-specific factors that may contribute to disease manifestation. Different elements may influence HSV-1 latency, reactivation, and disease outcomes in both natural and experimental settings. These variables should be taken into consideration when interpreting data, and in discussing the interactions between HSV-1 and AD development. These variables include (counter-clockwise from top left): Host immune responses and immune control; Choice of animal model; Reactivation rate differences between patients; Genetic differences between HSV-1 isolates or strains; Age at first exposure; Comorbid conditions (e.g., HIV infection, chronic obstructive pulmonary disease, etc.); Environmental influences, such as viral dose and number of exposures. Immune cell, animal, and host illustrations from <uri>Biorender.com</uri>.</p>
</caption>
<graphic xlink:href="viruses-11-00966-g001"></graphic>
</fig>
<fig id="viruses-11-00966-f002" orientation="portrait" position="float">
<label>Figure 2</label>
<caption>
<p>Persistent herpes simplex virus 1 (HSV-1) infection has periods of latency interspersed with periods of reactivation. The definition of latent viral infection requires a lack of infectious virus production between periods of active lytic replication. Infectious virions enter the nervous system at sensory nerve endings from the site of initial infection and are trafficked in retrograde to neuronal nuclei within peripheral ganglia. Within the neuronal nuclei, HSV-1 genomes form episomes, and lytic replication is repressed. However, during this time, low levels of lytic gene expression occur in the absence of infectious virion production, inducing local immune responses to dampen viral gene expression. Upon reactivation, infectious virions are produced and are trafficked in an anterograde direction back to the site of infection, causing recurrent skin infection and transmission to new hosts. The lack of infectious virion production and the formation of episomal DNA within host neuronal nuclei demonstrates that HSV-1 is not a chronic infection (i.e., with constant low-level virus production), despite its ability to produce low levels of lytic gene expression during latency. Diagram: neuronal cell cartoons from BioRender.com, graphical representation of HSV-1 infection dynamics adapted from [<xref ref-type="bibr" rid="B60-viruses-11-00966">60</xref>].</p>
</caption>
<graphic xlink:href="viruses-11-00966-g002"></graphic>
</fig>
<fig id="viruses-11-00966-f003" orientation="portrait" position="float">
<label>Figure 3</label>
<caption>
<p>Recurrent cycles of HSV-1 latency and reactivation may cause aberrant neuroinflammatory responses and synaptic dysfunction with advanced age. (<bold>A</bold>) If HSV-1 enters the central nervous system (CNS), latency will be established in the nucleus of infected neurons. Neuronal and glial expression of immune factors including members of the complement pathway and the MHCI processing and presentation pathway are expressed at homeostatic levels. (<bold>B</bold>) Local immune responses triggered by the expression of lytic viral genes, combined with multiple cycles of HSV-1 reactivation from latency, may over time lead to the deleterious expression of immune proteins. Aberrant expression of these proteins may cause the activation of microglia and astrocytes, as well as the dysregulation of neuron-neuron and/or neuron-glial communication. (<bold>C</bold>) Altered expression of immune factors at neuronal synapses may lead to neuronal over-stimulation and toxicity, under-stimulation and synaptic weakening, and/or synaptic pruning initiated by microglia. Diagram: figure adapted from [<xref ref-type="bibr" rid="B136-viruses-11-00966">136</xref>], cell type illustrations from <uri>BioRender.com</uri>.</p>
</caption>
<graphic xlink:href="viruses-11-00966-g003"></graphic>
</fig>
<fig id="viruses-11-00966-f004" orientation="portrait" position="float">
<label>Figure 4</label>
<caption>
<p>HSV-1 neurovirulence is strain- and host-dependent. (<bold>A</bold>) Different strains of HSV-1 (as represented by the different colored lines) exhibit distinct abilities to reach the CNS from inoculation at peripheral sites, causing variability in disease outcome in infected animals. Differences in the ability of specific HSV-1 strains to travel to the CNS can be the result of genomic variability between strains as well as (<bold>B</bold>) host-specific factors. These are schematized mortality data adapted from [<xref ref-type="bibr" rid="B49-viruses-11-00966">49</xref>,<xref ref-type="bibr" rid="B52-viruses-11-00966">52</xref>]. Mouse illustrations from <uri>BioRender.com</uri>.</p>
</caption>
<graphic xlink:href="viruses-11-00966-g004"></graphic>
</fig>
</floats-group>
</article>
</pmc-articleset>